Journal Article: Azithromycin Augments Bacterial Uptake and Anti-Inflammatory Macrophage Polarization in Cystic Fibrosis
Tarique, Abdullah A., Tuladhar, Neeraj, Kelk, Dean, Begum, Nelufa, Lucas, Richard M., Luo, Lin, Stow, Jennifer L., Wainwright, Claire E., Bell, Scott C., Sly, Peter D. and Fantino, Emmanuelle (2024). Azithromycin Augments Bacterial Uptake and Anti-Inflammatory Macrophage Polarization in Cystic Fibrosis. Cells, 13 (2) 166, 166. doi: 10.3390/cells13020166
Journal Article: Cystic fibrosis-related nontuberculous mycobacterial pulmonary disease
Baird, Timothy and Bell, Scott (2023). Cystic fibrosis-related nontuberculous mycobacterial pulmonary disease. Clinics in Chest Medicine, 44 (4), 847-860. doi: 10.1016/j.ccm.2023.06.008
Journal Article: Extended water stagnation in buildings during the COVID-19 pandemic increases the risks posed by opportunistic pathogens
Huang, Casey K., Weerasekara, Anjani, Lu, Ji, Carter, Robyn, Weynberg, Karen D., Thomson, Rachel, Bell, Scott and Guo, Jianhua (2023). Extended water stagnation in buildings during the COVID-19 pandemic increases the risks posed by opportunistic pathogens. Water Research: X, 21 100201. doi: 10.1016/j.wroa.2023.100201
(2021–2023) South Australian Health and Medical Research Institute Limited
(2020–2023) NHMRC Project Grant
(2020) Prince Charles Hospital Foundation
Risk and mitigation of cough aerosols for people with cystic fibrosis.
Doctor Philosophy
(2019) Doctor Philosophy
(2019) Master Philosophy
Bell, Scott C., Sufian, Beth S. and Passamano, James A. (2023). WORKING WITH CYSTIC FIBROSIS. Hodson and Geddes’ Cystic Fibrosis, Fifth Edition. (pp. 465-476) CRC Press. doi: 10.1201/9781003262763-44
Integrative Therapies for People with Cystic Fibrosis
Butler, Claire A. and Bell, Scott C. (2011). Integrative Therapies for People with Cystic Fibrosis. Integrative Therapies in Lung Health and Sleep. (pp. 113-126) Totowa, NJ: Humana Press. doi: 10.1007/978-1-61779-579-4_6
Anti-inflammatory therapies in bronchiectasis
Smith, D. J., Chang, A. B. and Bell, S. C. (2011). Anti-inflammatory therapies in bronchiectasis. Bronchiectasis. (pp. 233-238) edited by R.A. Floto and C.S. Haworth. Lausanne, Switzerland: European Respiratory Society. doi: 10.1183/1025448x.100004510
Kidd, Timothy J., Whiley, David M., Bell, Scott C. and Grimwood, Keith (2011). Pseudomonas. Molecular detection of human bacterial pathogens. (pp. 1009-1021) edited by Dongyou Liu. Boca Raton, FL, USA: Taylor & Francis.
Jones, A. M. and Bell, S. C. (2006). Cystic Fibrosis Infection with Clonal Strains of Pseudomonas Aeruginosa: Current Knowledge and Future Management. Cystic Fibrosis. (pp. 105-126) edited by K. Webb and F. Ratjen. London: Maney Publishing.
Antiobiotics in chronic obstructive pulmonary disease, bronchiectasis and cystic fibrosis
Yang, I. A., Kim, S. T. and Bell, S. C. (2005). Antiobiotics in chronic obstructive pulmonary disease, bronchiectasis and cystic fibrosis. Evidence-based Respiratory Medicine. (pp. 389-414) edited by P. Gibson. Carlton South, Australia: Blackwell Publishing Asia. doi: 10.1002/9780470987377.ch30
Tarique, Abdullah A., Tuladhar, Neeraj, Kelk, Dean, Begum, Nelufa, Lucas, Richard M., Luo, Lin, Stow, Jennifer L., Wainwright, Claire E., Bell, Scott C., Sly, Peter D. and Fantino, Emmanuelle (2024). Azithromycin Augments Bacterial Uptake and Anti-Inflammatory Macrophage Polarization in Cystic Fibrosis. Cells, 13 (2) 166, 166. doi: 10.3390/cells13020166
Cystic fibrosis-related nontuberculous mycobacterial pulmonary disease
Baird, Timothy and Bell, Scott (2023). Cystic fibrosis-related nontuberculous mycobacterial pulmonary disease. Clinics in Chest Medicine, 44 (4), 847-860. doi: 10.1016/j.ccm.2023.06.008
Huang, Casey K., Weerasekara, Anjani, Lu, Ji, Carter, Robyn, Weynberg, Karen D., Thomson, Rachel, Bell, Scott and Guo, Jianhua (2023). Extended water stagnation in buildings during the COVID-19 pandemic increases the risks posed by opportunistic pathogens. Water Research: X, 21 100201. doi: 10.1016/j.wroa.2023.100201
Kumar, Shanal and Bell, Scott (2023). Letter to the editor. Bone, 177 116890, 116890. doi: 10.1016/j.bone.2023.116890
Paraquat ingestion in an adult with cystic fibrosis (CF): Diagnostic and management dilemmas
Evans, Ieuan E. S., Kumar, Shanal, France, Megan, Smith, Daniel, Masel, Philip, Tay, George, Henderson, Daniel, Bell, Scott C. and Reid, David (2023). Paraquat ingestion in an adult with cystic fibrosis (CF): Diagnostic and management dilemmas. Respirology Case Reports, 11 (12) e01235, e01235. doi: 10.1002/rcr2.1235
Mayer-Hamblett, Nicole, Clancy, John Paul, Jain, Raksha, Donaldson, Scott H, Fajac, Isabelle, Goss, Christopher H, Polineni, Deepika, Ratjen, Felix, Quon, Bradley S, Zemanick, Edith T, Bell, Scott C, Davies, Jane C, Jain, Manu, Konstan, Michael W, Kerper, Natanya R, LaRosa, Tré, Mall, Marcus A, McKone, Edward, Pearson, Kelsie, Pilewski, Joseph M, Quittell, Lynne, Rayment, Jonathan H, Rowe, Steven M, Taylor-Cousar, Jennifer L, Retsch-Bogart, George and Downey, Damian G (2023). Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective. The Lancet Respiratory Medicine, 11 (10), 932-944. doi: 10.1016/s2213-2600(23)00297-7
Burke, Andrew, Carter, Robyn, Tolson, Carla, Congdon, Jacob, Duplancic, Christine, Bursle, Evan, Bell, Scott C., Roberts, Jason A. and Thomson, Rachel (2023). In vitro susceptibility testing of imipenem- relebactam and tedizolid against 102 Mycobacterium abscessus isolates. International Journal of Antimicrobial Agents, 62 (4) 106938, 1-6. doi: 10.1016/j.ijantimicag.2023.106938
A systematic review of the clinical impact of small colony variants in patients with cystic fibrosis
Ryan, Harrigan, Ballard, Emma, Stockwell, Rebecca E., Duplancic, Christine, Thomson, Rachel M., Smith, Kimberley and Bell, Scott C. (2023). A systematic review of the clinical impact of small colony variants in patients with cystic fibrosis. BMC Pulmonary Medicine, 23 (1) 323, 1-10. doi: 10.1186/s12890-023-02611-4
Ceftazidime resistance in Pseudomonas aeruginosa is multigenic and complex
Ramsay, Kay A., Rehman, Attika, Wardell, Samuel T., Martin, Lois W., Bell, Scott C., Patrick, Wayne M., Winstanley, Craig and Lamont, Iain L. (2023). Ceftazidime resistance in Pseudomonas aeruginosa is multigenic and complex. PLoS One, 18 (5) e0285856, 1-14. doi: 10.1371/journal.pone.0285856
Chang, Anne B., Bell, Scott C., Byrnes, Catherine A., Dawkins, Paul, Holland, Anne E., Kennedy, Emma, King, Paul T., Laird, Pamela, Mooney, Sarah, Morgan, Lucy, Parsons, Marianne, Poot, Betty, Toombs, Maree, Torzillo, Paul J. and Grimwood, Keith (2023). Thoracic Society of Australia and New Zealand (TSANZ ) position statement on chronic suppurative lung disease and bronchiectasis in children , adolescents and adults in Australia and New Zealand. Respirology, 28 (4), 339-349. doi: 10.1111/resp.14479
Do tobacco and cannabis use and co-use predict lung function: a longitudinal study
Najman, Jake M., Bell, Scott, Williams, Gail M., Clavarino, Alexandra M., Scott, James G., McGee, Tara R. and Mamun, Abdullah A. (2023). Do tobacco and cannabis use and co-use predict lung function: a longitudinal study. Respiratory Medicine, 208 107124, 107124. doi: 10.1016/j.rmed.2023.107124
Burke, Andrew, Thomson, Rachel M., Wainwright, Claire E. and Bell, Scott C. (2023). Nontuberculous Mycobacteria in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Regulator Modulators. Seminars in Respiratory and Critical Care Medicine, 44 (02), 287-296. doi: 10.1055/s-0042-1759883
Beyond borders: cystic fibrosis survival between Australia, Canada, France and New Zealand
Coriati, Adèle, Ma, Xiayi, Sykes, Jenna, Stanojevic, Sanja, Ruseckaite, Rasa, Lemonnier, Lydie, Dehillotte, Clémence, Tate, Jan, Byrnes, Catherine Ann, Bell, Scott C., Burgel, Pierre Regis and Stephenson, Anne L (2023). Beyond borders: cystic fibrosis survival between Australia, Canada, France and New Zealand. Thorax, 78 (3) 219086, 242-248. doi: 10.1136/thorax-2022-219086
Standards for the care of people with cystic fibrosis; establishing and maintaining health
Southern, Kevin, Addy, Charlotte, Bell, Scott, Bevan, Amanda, Borawska, Urzula, Brown, Catherine, Burgel, Pierre-Régis, Button, Brenda, Castellani, Carlo, Chansard, Audrey, Chilvers, Mark, Davies, Gwyneth, Davies, Jane, De Boeck, Kris, Declercq, Dimitri, Doumit, Michael, Drevinek, Pavel, Fajac, Isabelle, Gartner, Silvia, Georgiopoulos, Anna, Gursli, Sandra, Gramegna, Andrea, Hansen, Carina ME, Hug, Martin, Lammertyn, Elise, Landau, Edwina (Eddie) C., Langley, Ross, Mayer-Hamblett, Nicole, Middleton, Anna ... van Koningsbruggen-Rietschel, Silke (2023). Standards for the care of people with cystic fibrosis; establishing and maintaining health. Journal of Cystic Fibrosis. doi: 10.1016/j.jcf.2023.12.002
Davidson, Sarah J., France, Megan, Callaway, Leonie K., Lust, Karin, Chambers, Daniel, Hopkins, Peter, Bell, Scott C., Burr, Lucy, Keating, Rebecca and Barrett, Helen L. (2022). Pregnancy in women with cystic fibrosis and diabetes: an audit of outcomes at two tertiary obstetric hospitals in Australia in the pre-cystic fibrosis transmembrane conductance regulator modulator era. Obstetric Medicine, 16 (4), 217-221. doi: 10.1177/1753495x221146342
Targeted reduction of airborne viral transmission risk in long-term residential aged care
Brass, Amanda, Shoubridge, Andrew P., Larby, Nicolas, Elms, Levi, Sims, Sarah K., Flynn, Erin, Miller, Caroline, Crotty, Maria, Papanicolas, Lito E., Wesselingh, Steve L., Morawska, Lidia, Bell, Scott C., Taylor, Steven L. and Rogers, Geraint B. (2022). Targeted reduction of airborne viral transmission risk in long-term residential aged care. Age and Ageing, 51 (12) afac316, 1-5. doi: 10.1093/ageing/afac316
Survival of people with cystic fibrosis in Australia
Ruseckaite, Rasa, Salimi, Farhad, Earnest, Arul, Bell, Scott C., Douglas, Tonia, Frayman, Katherine, Keatley, Lucy, King, Susannah, Kotsimbos, Tom, Middleton, Peter G., Morey, Sue, Mulrennan, Siobhain, Schultz, Andre, Wainwright, Claire, Ward, Nathan, Wark, Peter and Ahern, Susannah (2022). Survival of people with cystic fibrosis in Australia. Scientific Reports, 12 (1) 19748, 1-9. doi: 10.1038/s41598-022-24374-4
Characterizing and correcting immune dysfunction in non-tuberculous mycobacterial disease
Ratnatunga, Champa N., Tungatt, Katie, Proietti, Carla, Halstrom, Sam, Holt, Michael R., Lutzky, Viviana P., Price, Patricia, Doolan, Denise L., Bell, Scott C., Field, Matt A., Kupz, Andreas, Thomson, Rachel M. and Miles, John J. (2022). Characterizing and correcting immune dysfunction in non-tuberculous mycobacterial disease. Frontiers in Immunology, 13 1047781, 1-20. doi: 10.3389/fimmu.2022.1047781
Madden, Danielle E., McCarthy, Kate L., Bell, Scott C., Olagoke, Olusola, Baird, Timothy, Neill, Jane, Ramsay, Kay A., Kidd, Timothy J., Stewart, Adam G., Subedi, Shradha, Choong, Keat, Fraser, Tamieka A., Sarovich, Derek S. and Price, Erin P. (2022). Rapid fluoroquinolone resistance detection in Pseudomonas aeruginosa using mismatch amplification mutation assay-based real-time PCR. Journal of Medical Microbiology, 71 (10) 001593, 1-10. doi: 10.1099/jmm.0.001593
Nguyen, Thi Tham, He, Congrong, Carter, Robyn, Ballard, Emma L., Smith, Kim, Groth, Robert, Jaatinen, Esa, Kidd, Timothy J., Nguyen, Thuy-Khanh, Stockwell, Rebecca E., Tay, George, Johnson, Graham R., Bell, Scott C. and Knibbs, Luke D. (2022). The effectiveness of ultraviolet-C (UV-C) irradiation on the viability of airborne Pseudomonas aeruginosa. International Journal of Environmental Research and Public Health, 19 (20) 13706, 1-15. doi: 10.3390/ijerph192013706
Nguyen, Thi Tham, He, Congrong, Carter, Robyn, Ballard, Emma L., Smith, Kim, Groth, Robert, Jaatinen, Esa, Kidd, Timothy J., Thomson, Rachel, Tay, George, Johnson, Graham R., Bell, Scott C. and Knibbs, Luke D. (2022). Quantifying the effectiveness of ultraviolet-C (UV-C) light at inactivating airborne Mycobacterium abscessus. Journal of Hospital Infection, 132, 133-139. doi: 10.1016/j.jhin.2022.10.008
Antimicrobial stewardship in cystic fibrosis
Lloyd, Elizabeth C., Cogen, Jonathan D., Maples, Holly, Bell, Scott C. and Saiman, Lisa (2022). Antimicrobial stewardship in cystic fibrosis. Journal of the Pediatric Infectious Diseases Society, 11 (2), S53-S61. doi: 10.1093/jpids/piac071
Smith, Daniel J and Bell, Scott C (2022). Next steps on managing pulmonary exacerbations: Is the future less, shorter and or more targeted treatments?. Journal of Cystic Fibrosis, 21 (5), 739-740. doi: 10.1016/j.jcf.2022.08.015
Carr, Siobhán B, McClenaghan, Elliot, Elbert, Alexander, Faro, Albert, Cosgriff, Rebecca, Abdrakhmanov, Olzhas, Brownlee, Keith, Burgel, Pierre-Régis, Byrnes, Catherine A, Cheng, Stephanie Y, Colombo, Carla, Corvol, Harriet, Daneau, Géraldine, Goss, Christopher H, Gulmans, Vincent, Gutierrez, Hector, Harutyunyan, Satenik, Helmick, Meagan, Jung, Andreas, Kashirskaya, Nataliya, McKone, Edward, Melo, Joel, Middleton, Peter G, Mondejar-Lopez, Pedro, de Monestrol, Isabelle, Nährlich, Lutz, Padoan, Rita, Parker, Megan, Pastor-Vivero, M Dolores ... on behalf of the CF Registry Global Collaboration (2022). Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: a global observational study. Journal of Cystic Fibrosis, 21 (4), e221-e231. doi: 10.1016/j.jcf.2022.06.006
Emerging nonpulmonary complications for adults with cystic fibrosis
Chin, Melanie, Brennan, Amanda L. and Bell, Scott C. (2022). Emerging nonpulmonary complications for adults with cystic fibrosis. Chest, 161 (5), 1211-1224. doi: 10.1016/j.chest.2021.11.001
Madden, Danielle E., Olagoke, Olusola, Baird, Timothy, Neill, Jane, Ramsay, Kay A., Fraser, Tamieka A., Bell, Scott C., Sarovich, Derek S. and Price, Erin P. (2022). Express yourself: quantitative real-time PCR assays for rapid chromosomal antimicrobial resistance detection in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy, 66 (5) e0020422, e0020422. doi: 10.1128/aac.00204-22
CD161 expression defines new human γδ T cell subsets
Karunathilaka, Amali, Halstrom, Samuel, Price, Patricia, Holt, Michael, Lutzky, Viviana P., Doolan, Denise L., Kupz, Andreas, Bell, Scott C., Thomson, Rachel M., Miles, John J. and Ratnatunga, Champa N. (2022). CD161 expression defines new human γδ T cell subsets. Immunity and Ageing, 19 (1) 11, 1-8. doi: 10.1186/s12979-022-00269-w
Webb, Kasey A., Olagoke, Olusola, Baird, Timothy, Neill, Jane, Pham, Amy, Wells, Timothy J., Ramsay, Kay A., Bell, Scott C., Sarovich, Derek S. and Price, Erin P. (2022). Genomic diversity and antimicrobial resistance of Prevotella species isolated from chronic lung disease airways. Microbial Genomics, 8 (2) 000754. doi: 10.1099/mgen.0.000754
Cystic fibrosis: a disease in transformation, yet more work to be done!
Ramsey, Bonnie W and Bell, Scott C. (2022). Cystic fibrosis: a disease in transformation, yet more work to be done!. American Journal of Respiratory and Critical Care Medicine, 205 (5), 487-489. doi: 10.1164/rccm.202112-2782ed
Nguyen, Thi Tham, Johnson, Graham R., Bell, Scott C. and Knibbs, Luke D. (2022). A systematic literature review of indoor air disinfection techniques for airborne bacterial respiratory pathogens. International Journal of Environmental Research and Public Health, 19 (3) 1197. doi: 10.3390/ijerph19031197
Neutrophil respiratory burst activity is not exaggerated in cystic fibrosis
Kelk, Dean, Logan, Jayden, Andersen, Isabella, Gutierrez Cardenas, Diana, Bell, Scott C., Wainwright, Claire E., Sly, Peter D. and Fantino, Emmanuelle (2022). Neutrophil respiratory burst activity is not exaggerated in cystic fibrosis. Journal of Cystic Fibrosis, 21 (4), 707-712. doi: 10.1016/j.jcf.2021.12.015
What it takes to build a health services innovation training program
Martin, Elizabeth, Campbell, Megan, Parsonage, William, Rosengren, David, Bell, Scott C. and Graves, Nick (2021). What it takes to build a health services innovation training program. International Journal of Medical Education, 12, 259-263. doi: 10.5116/ijme.61af.30bd
Dissemination of Mycobacterium abscessus via global transmission networks
Ruis, Christopher, Bryant, Josephine M., Bell, Scott C., Thomson, Rachel, Davidson, Rebecca M., Hasan, Nabeeh A., van Ingen, Jakko, Strong, Michael, Floto, R. Andres and Parkhill, Julian (2021). Dissemination of Mycobacterium abscessus via global transmission networks. Nature Microbiology, 6 (10), 1279-1288. doi: 10.1038/s41564-021-00963-3
Brass, Amanda, Shoubridge, Andrew P., Crotty, Maria, Morawska, Lidia, Bell, Scott C., Qiao, Ming, Woodman, Richard J., Whitehead, Craig, Inacio, Maria C., Miller, Caroline, Corlis, Megan, Larby, Nicolas, Elms, Levi, Sims, Sarah K., Taylor, Steven L., Flynn, Erin, Papanicolas, Lito E. and Rogers, Geraint B. (2021). Prevention of SARS-CoV-2 (COVID-19) transmission in residential aged care using ultraviolet light (PETRA): a two-arm crossover randomised controlled trial protocol. BMC Infectious Diseases, 21 (1) 967. doi: 10.1186/s12879-021-06659-7
Semasinghe Bandaralage, Sahan P., Tay, George, Hay, Karen, Megram, Emma, Smith, Daniel, Gadowski, Tahlia, Wright, Eimear, France, Megan, Bell, Scott and Reid, David (2021). Outcomes of artery embolisation for cystic fibrosis patients with haemoptysis: a 20-year experience at a major Australian tertiary centre. Internal Medicine Journal, 51 (9), 1526-1529. doi: 10.1111/imj.15483
Pham, Amy, Ledger, Emma L., Coggon, Carrie F., Henderson, Ian R., Reid, David W., Bell, Scott C., Smith, Daniel J. and Wells, Timothy J. (2021). Anti-LPS IgA and IgG can inhibit serum killing of Pseudomonas aeruginosa in patients with cystic fibrosis. Infection and Immunity, 89 (12) e00412-21, e0041221. doi: 10.1128/iai.00412-21
Wark, Peter AB, MacIntyre, C Raina, Bell, Scott, Oliver, Brian and Marks, Guy B (2021). We are not doing enough to prevent the spread of COVID-19 and other respiratory viruses in Australian hospitals. Medical Journal of Australia, 215 (4), 152-153.e1. doi: 10.5694/mja2.51183
Burke, Andrew, Smith, Daniel, Coulter, Chris, Bell, Scott C., Thomson, Rachel and Roberts, Jason A. (2021). Clinical pharmacokinetic and pharmacodynamic considerations in the drug treatment of non-tuberculous mycobacteria in cystic fibrosis. Clinical Pharmacokinetics, 60 (9), 1081-1102. doi: 10.1007/s40262-021-01010-4
Antimicrobial resistance: concerns of healthcare providers and people with CF
Bullington, Wendy, Hempstead, Sarah, Smyth, Alan R., Drevinek, Pavel, Saiman, Lisa, Waters, Valerie J., Bell, Scott C., VanDevanter, Donald R., Flume, Patrick A., Elborn, Stuart and Muhlebach, Marianne S (2021). Antimicrobial resistance: concerns of healthcare providers and people with CF. Journal of Cystic Fibrosis, 20 (3), 407-412. doi: 10.1016/j.jcf.2020.05.009
Bordin, Amanda, Pandey, Sushil, Coulter, Christopher, Syrmis, Melanie, Pardo, Carolyn, Hackett, Hazel, Bell, Scott C., Wainwright, Claire E., Nimmo, Graeme R., Jennison, Amy V., Clark, Julia E. and Whiley, David M. (2021). Rapid macrolide and amikacin resistance testing for Mycobacterium abscessus in people with cystic fibrosis. Journal of Medical Microbiology, 70 (4) 001349, 1-11. doi: 10.1099/jmm.0.001349
Redesign of the Australian Cystic Fibrosis Data Registry: a multidisciplinary collaboration
Ahern, Susannah, Dean, Joanne, Liman, John, Ruseckaite, Rasa, Burke, Nettie, Gollan, Morgan, Keatley, Lucy, King, Susannah, Kotsimbos, Tom, Middleton, Peter G., Schultz, Andre, Wainwright, Claire, Wark, Peter and Bell, Scott (2021). Redesign of the Australian Cystic Fibrosis Data Registry: a multidisciplinary collaboration. Paediatric Respiratory Reviews, 37, 37-43. doi: 10.1016/j.prrv.2020.03.001
Emergence and impact of oprD mutations in Pseudomonas aeruginosa strains in cystic fibrosis
Sherrard, Laura J., Wee, Bryan A., Duplancic, Christine, Ramsay, Kay A., Dave, Keyur A., Ballard, Emma, Wainwright, Claire E., Grimwood, Keith, Sidjabat, Hanna E., Whiley, David M., Beatson, Scott A., Kidd, Timothy J. and Bell, Scott C. (2021). Emergence and impact of oprD mutations in Pseudomonas aeruginosa strains in cystic fibrosis. Journal of Cystic Fibrosis, 21 (1), e35-e43. doi: 10.1016/j.jcf.2021.03.007
Hall, Kathleen, Maxwell, Lyndal, Cobb, Robyn, Steele, Michael, Chambers, Rebecca, Roll, Mark, Bell, Scott Cameron and Kuys, Suzanne (2021). Physiotherapy service provision in a specialist adult cystic fibrosis service: a pre-post design study with the inclusion of an allied health assistant. Chronic Respiratory Disease, 18, 14799731211017895. doi: 10.1177/14799731211017895
Sexual and reproductive health in cystic fibrosis
Frayman, Katherine B., Chin, Melanie, Sawyer, Susan M. and Bell, Scott C. (2020). Sexual and reproductive health in cystic fibrosis. Current Opinion in Pulmonary Medicine, 26 (6), 685-695. doi: 10.1097/MCP.0000000000000731
Thomson, Rachel M., Furuya-Kanamori, Luis, Coffey, Cushla, Bell, Scott C., Knibbs, Luke D. and Lau, Colleen L. (2020). Influence of climate variables on the rising incidence of nontuberculous mycobacterial (NTM) infections in Queensland, Australia 2001–2016. Science of the Total Environment, 740 139796, 139796. doi: 10.1016/j.scitotenv.2020.139796
Earnest, Arul, Salimi, Farhad, Wainwright, Claire E., Bell, Scott C., Ruseckaite, Rasa, Ranger, Tom, Kotsimbos, Tom and Ahern, Susannah (2020). Lung function over the life course of paediatric and adult patients with cystic fibrosis from a large multi-centre registry. Scientific Reports, 10 (1) 17421, 17421. doi: 10.1038/s41598-020-74502-1
Cystic fibrosis–Ten promising therapeutic approaches in the current era of care
Somayaji, Ranjani, Nichols, Dave P. and Bell, Scott C. (2020). Cystic fibrosis–Ten promising therapeutic approaches in the current era of care. Expert Opinion on Investigational Drugs, 29 (10), 1107-1124. doi: 10.1080/13543784.2020.1805733
Price, Erin P., Soler Arango, Valentina, Kidd, Timothy J., Fraser, Tamieka A., Nguyen, Thuy-Khanh, Bell, Scott C. and Sarovich, Derek S. (2020). Duplex real-time PCR assay for the simultaneous detection of Achromobacter xylosoxidans and Achromobacter spp. Microbial Genomics, 6 (7) 000406, 1-11. doi: 10.1099/mgen.0.000406
Hall, Kathleen, Maxwell, Lyndal, Cobb, Robyn, Chambers, Rebecca, Roll, Mark, Bell, Scott C. and Kuys, Suzanne (2020). Benchmarking service provision, scope of practice, and skill mix for physiotherapists in adult cystic fibrosis care delivery. Physiotherapy Theory and Practice, 38 (4), 1-7. doi: 10.1080/09593985.2020.1777606
A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis
Cosgriff, Rebecca, Ahern, Susannah, Bell, Scott C., Brownlee, Keith, Burgel, Pierre-Régis, Byrnes, Cass, Corvol, Harriet, Cheng, Stephanie Y., Elbert, Alexander, Faro, Albert, Goss, Christopher H., Gulmans, Vincent, Marshall, Bruce C., McKone, Edward, Middleton, Peter G., Ruseckaite, Rasa, Stephenson, Anne L. and Carr, Siobhán B (2020). A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis. Journal of Cystic Fibrosis, 19 (3), 355-358. doi: 10.1016/j.jcf.2020.04.012
Antimicrobial resistance in cystic fibrosis: A Delphi approach to defining best practices
Zemanick, Edith, Burgel, Pierre-Régis, Taccetti, Giovanni, Holmes, Alison, Ratjen, Felix, Byrnes, Catherine A., Waters, Valerie J., Bell, Scott C., VanDevanter, Donald R., Stuart Elborn, J. and Flume, Patrick A. (2020). Antimicrobial resistance in cystic fibrosis: A Delphi approach to defining best practices. Journal of Cystic Fibrosis, 19 (3), 370-375. doi: 10.1016/j.jcf.2019.10.006
Leisman, Daniel E., Harhay, Michael O., Lederer, David J., Abramson, Michael, Adjei, Alex A., Bakker, Jan, Ballas, Zuhair K., Barreiro, Esther, Bell, Scott C., Bellomo, Rinaldo, Bernstein, Jonathan A., Branson, Richard D., Brusasco, Vito, Chalmers, James D., Chokroverty, Sudhansu, Citerio, Giuseppe, Collop, Nancy A., Cooke, Colin R., Crapo, James D., Donaldson, Gavin, Fitzgerald, Dominic A., Grainger, Emma, Hale, Lauren, Herth, Felix J., Kochanek, Patrick M., Marks, Guy, Moorman, J. Randall, Ost, David E., Schatz, Michael ... Maslove, David M. (2020). Development and reporting of prediction models: guidance for authors from editors of respiratory, sleep, and critical care journals. Critical Care Medicine, 48 (5), 623-633. doi: 10.1097/CCM.0000000000004246
Seven P's of publication practices
Bell, Scott C., Flume, Patrick A. and Castellani, Carlo (2020). Seven P's of publication practices. Journal of Cystic Fibrosis, 19 (3), 333-335. doi: 10.1016/j.jcf.2020.02.007
Pearson, Talima, Sahl, Jason W., Hepp, Crystal M., Handady, Karthik, Hornstra, Heidie, Vazquez, Adam J., Settles, Erik, Mayo, Mark, Kaestli, Mirjam, Williamson, Charles H. D., Price, Erin P., Sarovich, Derek S., Cook, James M., Wolken, Spenser R., Bowen, Richard A., Tuanyok, Apichai, Foster, Jeffrey T., Drees, Kevin P., Kidd, Timothy J., Bell, Scott C., Currie, Bart J. and Keim, Paul (2020). Pathogen to commensal? Longitudinal within-host population dynamics, evolution, and adaptation during a chronic >16-year Burkholderia pseudomallei infection. PLoS Pathogens, 16 (3) e1008298, e1008298. doi: 10.1371/journal.ppat.1008298
Flume, Patrick, Bell, Scott C. and Castellani, Carlo (2020). Pursuit of Equity. Journal of Cystic Fibrosis, 19 (2), 171. doi: 10.1016/j.jcf.2020.02.019
Finding the relevance of antimicrobial stewardship for cystic fibrosis
Cogen, Jonathan D., Kahl, Barbara C., Maples, Holly, McColley, Susanna A., Roberts, Jason A., Winthrop, Kevin L., Morris, Andrew M., Holmes, Alison, Flume, Patrick A., VanDevanter, Donald R., Waters, Valerie, Muhlebach, Marianne S., Elborn, J. Stuart, Saiman, Lisa and Bell, Scott C. (2020). Finding the relevance of antimicrobial stewardship for cystic fibrosis. Journal of Cystic Fibrosis, 19 (4), 511-520. doi: 10.1016/j.jcf.2020.02.012
Geake, James, Ballard, Emma, O'Rourke, Peter, Wainwright, Claire E., Reid, David W. and Bell, Scott C. (2020). Centralised versus outreach models of cystic fibrosis care should be tailored to the needs of the individual patient. Internal Medicine Journal, 50 (2), 232-235. doi: 10.1111/imj.14724
Current infection control practices used in Australian and New Zealand cystic fibrosis centers
Stockwell, Rebecca Elizabeth, Wood, Michelle ELizabeth, Ballard, Emma, Moore, Vanessa, Wainwright, Claire Elizabeth and Bell, Scott Cameron (2020). Current infection control practices used in Australian and New Zealand cystic fibrosis centers. BMC Pulmonary Medicine, 20 (1) 16, 16. doi: 10.1186/s12890-020-1052-y
Building global development strategies for cf therapeutics during a transitional cftr modulator era
Mayer-Hamblett, N., van Koningsbruggen-Rietschel, S., Nichols, D. P., VanDevanter, D. R., Davies, J. C., Lee, T., Durmowicz, A. G., Ratjen, F., Konstan, M. W., Pearson, K., Bell, S. C., Clancy, J. P., Taylor-Cousar, J. L., De Boeck, K., Donaldson, S. H., Downey, D. G., Flume, P. A., Drevinek, P., Goss, C. H., Fajac, I., Magaret, A. S., Quon, B. S., Singleton, S. M., VanDalfsen, J. M. and Retsch-Bogart, G. Z. (2020). Building global development strategies for cf therapeutics during a transitional cftr modulator era. Journal of Cystic Fibrosis, 19 (5), 677-687. doi: 10.1016/j.jcf.2020.05.011
The future of cystic fibrosis care: a global perspective
Bell, Scott C, Mall, Marcus A, Gutierrez, Hector, Macek, Milan, Madge, Susan, Davies, Jane C, Burgel, Pierre-Régis, Tullis, Elizabeth, Castaños, Claudio, Castellani, Carlo, Byrnes, Catherine A, Cathcart, Fiona, Chotirmall, Sanjay H, Cosgriff, Rebecca, Eichler, Irmgard, Fajac, Isabelle, Goss, Christopher H, Drevinek, Pavel, Farrell, Philip M, Gravelle, Anna M, Havermans, Trudy, Mayer-Hamblett, Nicole, Kashirskaya, Nataliya, Kerem, Eitan, Mathew, Joseph L, McKone, Edward F, Naehrlich, Lutz, Nasr, Samya Z, Oates, Gabriela R ... Ratjen, Felix (2020). The future of cystic fibrosis care: a global perspective. The Lancet Respiratory Medicine, 8 (1), 65-124. doi: 10.1016/S2213-2600(19)30337-6
The rise of non-tuberculosis mycobacterial lung disease
Ratnatunga, Champa N., Lutzky, Viviana P., Kupz, Andreas, Doolan, Denise L., Reid, David W., Field, Matthew, Bell, Scott C., Thomson, Rachel M. and Miles, John J. (2020). The rise of non-tuberculosis mycobacterial lung disease. Frontiers in Immunology, 11 303, 303. doi: 10.3389/fimmu.2020.00303
Disruption in research publishing – the open access revolution
Bell, Scott C., Castellani, Carlo and Flume, Patrick A. (2019). Disruption in research publishing – the open access revolution. Journal of Cystic Fibrosis, 18 (6), 747-749. doi: 10.1016/j.jcf.2019.10.024
Ramsay, Kay A., Wardell, Samuel J. T., Patrick, Wayne M., Brockway, Ben, Reid, David W., Winstanley, Craig, Bell, Scott C. and Lamont, Iain L. (2019). Genomic and phenotypic comparison of environmental and patient-derived isolates of Pseudomonas aeruginosa suggest that antimicrobial resistance is rare within the environment. Journal of Medical Microbiology, 68 (11), 1591-1595. doi: 10.1099/jmm.0.001085
Prevention of chronic infection with Pseudomonas aeruginosa infection in cystic fibrosis
Zemanick, Edith T. and Bell, Scott C. (2019). Prevention of chronic infection with Pseudomonas aeruginosa infection in cystic fibrosis. Current Opinion in Pulmonary Medicine, 25 (6), 636-645. doi: 10.1097/MCP.0000000000000616
Fraser, Tamieka A., Bell, Mikaela G., Harris, Patrick N. A., Bell, Scott C., Bergh, Haakon, Thuy-Khanh Nguyen,, Kidd, Timothy J., Nimmo, Graeme R., Sarovich, Derek S. and Price, Erin P. (2019). Quantitative real-time PCR assay for the rapid identification of the intrinsically multidrug-resistant bacterial pathogen Stenotrophomonas maltophilia. Microbial Genomics, 5 (10) 000307. doi: 10.1099/mgen.0.000307
Bell, Scott C., Barry, Peter J., De Boeck, Kris, Drevinek, Pavel, Elborn, J. Stuart, Plant, Barry J., Minić, Predag, Van Braeckel, Eva, Verhulst, Stijn, Muller, Karine, Kanters, Desirée, Bellaire, Susan, de Kock, Herman, Geller, David E., Conrath, Katja, Van de Steen, Olivier and van der Ent, Kors (2019). CFTR activity is enhanced by the novel corrector GLPG2222, given with and without ivacaftor in two randomized trials. Journal of Cystic Fibrosis, 18 (5), 700-707. doi: 10.1016/j.jcf.2019.04.014
Bell, Scott C., Mainz, Jochen G., MacGregor, Gordon, Madge, Susan, MacEy, Julie, Fridman, Moshe, Suthoff, Ellison D., Narayanan, Siva and Kinnman, Nils (2019). Patient-reported outcomes in patients with cystic fibrosis with a G551D mutation on ivacaftor treatment: Results from a cross-sectional study. BMC Pulmonary Medicine, 19 (1) 146, 1-9. doi: 10.1186/s12890-019-0887-6
Indoor hospital air and the impact of ventilation on bioaerosols: a systematic review
Stockwell, Rebecca E., Ballard, Emma L., O’Rourke, Peter, Knibbs, Luke D., Morawska, Lidia and Bell, Scott C. (2019). Indoor hospital air and the impact of ventilation on bioaerosols: a systematic review. Journal of Hospital Infection, 103 (2), 175-184. doi: 10.1016/j.jhin.2019.06.016
Non-invasive ventilation versus oxygen therapy in cystic fibrosis: a 12-month randomized trial
Milross, Maree A., Piper, Amanda J., Dwyer, Tiffany J., Wong, Keith, Bell, Scott C., Bye, Peter T. P., Robbins, Lisel, Dobbin, Catherine, Moriarty, Carmel, Willson, G., Norman, M., Regnis, Jeff, Sullivan, Colin, Grunstein, Ron and Douglas, James (2019). Non-invasive ventilation versus oxygen therapy in cystic fibrosis: a 12-month randomized trial. Respirology, 24 (12) resp.13604, 1191-1197. doi: 10.1111/resp.13604
Matson, A. G., Bunting, J. P., Kaul, A., Smith, D. J., Stonestreet, J., Herd, K., Hodgson, R. S. and Bell, S. C. (2019). A non-randomised single centre cohort study, comparing standard and modified bowel preparations, in adults with cystic fibrosis requiring colonoscopy. BMC Gastroenterology, 19 (1) 89. doi: 10.1186/s12876-019-0979-z
Multi-centre ethics and research governance review can impede non-interventional clinical research
Duplancic, Christine, Crough, Tania, Bell, Scott C., Australian NTM in CF Study Group and Thomson, Rachel (2019). Multi-centre ethics and research governance review can impede non-interventional clinical research. Internal Medicine Journal, 49 (6), 722-728. doi: 10.1111/imj.14158
Abolition of Pseudomonas aeruginosa AUST-01 from an Australian CF center: Do other strains remain?
Kidd, Timothy J, Grimwood, Keith and Bell, Scott C (2019). Abolition of Pseudomonas aeruginosa AUST-01 from an Australian CF center: Do other strains remain?. Pediatric Pulmonology, 54 (5), 515-516. doi: 10.1002/ppul.24258
Reply: More on causal inference studies
Lederer, David J., Bell, Scott C., Smyth, Alan R. and Chalmers, James D. (2019). Reply: More on causal inference studies. Annals of the American Thoracic Society, 16 (5), 646-646. doi: 10.1513/AnnalsATS.201901-070LE
Infection risks for patients from healthcare workers with cystic fibrosis - Reply
Bell, Scott C. and Stuart, Rhonda L. (2019). Infection risks for patients from healthcare workers with cystic fibrosis - Reply. Respirology, 24 (4), 393-394. doi: 10.1111/resp.13489
Stockwell, Rebecca E., Chin, Melanie, Johnson, Graham R., Wood, Michelle E., Sherrard, Laura J., Ballard, Emma, O'Rourke, Peter, Ramsay, Kay A., Kidd, Timothy J., Jabbour, Nassib, Thomson, Rachel M., Knibbs, Luke D., Morawska, Lidia and Bell, Scott C. (2019). Transmission of bacteria in bronchiectasis and chronic obstructive pulmonary disease: Low burden of cough aerosols. Respirology, 24 (10) resp.13544, 980-987. doi: 10.1111/resp.13544
Somayaji, Ranjani, Parkins, Michael D., Shah, Anand, Martiniano, Stacey L., Tunney, Michael M., Kahle, Jennifer S., Waters, Valerie J., Elborn, J. Stuart, Bell, Scott C., Flume, Patrick A. and VanDevanter, Donald R. (2019). Antimicrobial susceptibility testing (AST) and associated clinical outcomes in individuals with cystic fibrosis: A systematic review. Journal of Cystic Fibrosis, 18 (2), 236-243. doi: 10.1016/j.jcf.2019.01.008
Mutations in the HFE gene can be associated with increased lung disease severity in cystic fibrosis
Smith, Daniel J., Klein, Kerenaftali, Hartel, Gunter, Wainwright, Claire E., Bell, Scott C., Anderson, Gregory J. and Reid, David W. (2019). Mutations in the HFE gene can be associated with increased lung disease severity in cystic fibrosis. Gene, 683, 12-17. doi: 10.1016/j.gene.2018.10.002
Sherrard, Laura J., Tai, Anna S., Wee, Bryan A., Ramsay, Kay A., Kidd, Timothy J., Ben Zakour, Nouri L., Whiley, David M., Beatson, Scott A. and Bell, Scott C. (2019). Correction: Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in cystic fibrosis (PLoS One (2017) 12:3 (e0172179) DOI: 10.1371/journal.pone.0172179). PLoS ONE, 14 (1) e0210929. doi: 10.1371/journal.pone.0210929
Control of confounding and reporting of results in causal inference studies
Lederer, David J., Bell, Scott C., Branson, Richard D., Chalmers, James D., Marshall, Rachel, Maslove, David M., Ost, David E., Punjabi, Naresh M., Schatz, Michael, Smyth, Alan R., Stewart, Paul W., Suissa, Samy, Adjei, Alex A., Akdis, Cezmi A., Azoulay, Élie, Bakker, Jan, Ballas, Zuhair K., Bardin, Philip G., Barreiro, Esther, Bellomo, Rinaldo, Bernstein, Jonathan A., Brusasco, Vito, Buchman, Timothy G., Chokroverty, Sudhansu, Collop, Nancy A., Crapo, James D., Fitzgerald, Dominic A., Hale, Lauren, Hart, Nicholas ... Vincent, Jean-Louis (2019). Control of confounding and reporting of results in causal inference studies. Annals of the American Thoracic Society, 16 (1), 22-28. doi: 10.1513/AnnalsATS.201808-564PS
Bell, Scott C., Castellani, Carlo and Flume, Patrick A. (2019). JCF – progress in 2018. Journal of Cystic Fibrosis, 18 (1), 1-5. doi: 10.1016/j.jcf.2018.12.008
Reply to: Use of masks in cystic fibrosis patients
Wood, Michelle E, Stockwell, Rebecca E and Bell, Scott C (2018). Reply to: Use of masks in cystic fibrosis patients. American Journal of Respiratory and Critical Care Medicine, 198 (12) rccm.201808-1476LE, 1589-1590. doi: 10.1164/rccm.201808-1476LE
Antimicrobial resistance in cystic fibrosis: Does it matter?
Flume, Patrick A., Waters, Valerie J., Bell, Scott C., Van Devanter, Donald R. and Stuart Elborn, J. (2018). Antimicrobial resistance in cystic fibrosis: Does it matter?. Journal of Cystic Fibrosis, 17 (6), 687-689. doi: 10.1016/j.jcf.2018.08.015
Bronchiectasis: treatment decisions for pulmonary exacerbations and their prevention
Bell, Scott C., Elborn, Joseph S. and Byrnes, Catherine A. (2018). Bronchiectasis: treatment decisions for pulmonary exacerbations and their prevention. Respirology, 23 (11), 1006-1022. doi: 10.1111/resp.13398
Defining antimicrobial resistance in cystic fibrosis
Kidd, Timothy J., Canton, Rafael, Ekkelenkamp, Miquel, Johansen, Helle Krogh, Gilligan, Peter, LiPuma, John J., Bell, Scott C., Elborn, J. Stuart, Flume, Patrick A., VanDevanter, Donald R. and Waters, Valerie J. (2018). Defining antimicrobial resistance in cystic fibrosis. Journal of Cystic Fibrosis, 17 (6), 696-704. doi: 10.1016/j.jcf.2018.08.014
Martin, Lois W., Robson, Cynthia L., Watts, Annabelle M., Gray, Andrew R., Wainwright, Claire E., Bell, Scott C., Ramsay, Kay A., Kidd, Timothy J., Reid, David W., Brockway, Ben and Lamont, Iain L. (2018). Expression of Pseudomonas aeruginosa antibiotic resistance genes varies greatly during infections in cystic fibrosis patients. Antimicrobial Agents and Chemotherapy, 62 (11) e01789-18. doi: 10.1128/AAC.01789-18
Nagy, Béla, Bene, Zsolt, Fejes, Zsolt, Heltshe, Sonya L, Reid, David, Ronan, Nicola J, McCarthy, Yvonne, Smith, Daniel, Nagy, Attila, Joseloff, Elizabeth, Balla, György, Kappelmayer, János, Macek, Milan, Bell, Scott C, Plant, Barry J, Amaral, Margarida D and Balogh, István (2018). Human epididymis protein 4 (HE4) levels inversely correlate with lung function improvement (delta FEV1) in cystic fibrosis patients receiving ivacaftor treatment. Journal of Cystic Fibrosis, 18 (2), 271-277. doi: 10.1016/j.jcf.2018.08.013
Work environment risks for health care workers with cystic fibrosis
Bell, Scott C., Armstrong, David, Harrington, Glenys, Jardine, Luke, Divakaran, Rebekah, Loff, Bebe, Middleton, Peter G., McDonald, Tim, Rowland, Karen, Wishart, Michael, Wood, Michelle E. and Stuart, Rhonda L. (2018). Work environment risks for health care workers with cystic fibrosis. Respirology, 23 (12), 1190-1197. doi: 10.1111/resp.13404
Wee, Bryan A., Tai, Anna S., Sherrard, Laura J., Ben Zakour, Nouri L., Hanks, Kirt R., Kidd, Timothy J., Ramsay, Kay A., Lamont, Iain, Whiley, David M., Bell, Scott C. and Beatson, Scott A. (2018). Whole genome sequencing reveals the emergence of a Pseudomonas aeruginosa shared strain sub-lineage among patients treated within a single cystic fibrosis centre. BMC Genomics, 19 (1) 644, 644. doi: 10.1186/s12864-018-5018-x
Stockwell, Rebecca E., Wood, Michelle E., He, Congrong, Sherrard, Laura J., Ballard, Emma L., Kidd, Timothy J., Johnson, Graham R., Knibbs, Luke D., Morawska, Lidia, Bell, Scott C., CF Cough Aerosol Group and Duplancic, Christine (2018). Face Masks Reduce the Release of Pseudomonas aeruginosa Cough Aerosols when Worn for Clinically-Relevant Time Periods. American Journal of Respiratory and Critical Care Medicine, 198 (10) rccm.201805-0823LE, 1339-1342. doi: 10.1164/rccm.201805-0823LE
Transcriptomic analysis of longitudinal Burkholderia pseudomallei infecting the cystic fibrosis lung
Price, Erin P., Viberg, Linda T., Kidd, Timothy J., Bell, Scott C., Currie, Bart J. and Sarovich, Derek S. (2018). Transcriptomic analysis of longitudinal Burkholderia pseudomallei infecting the cystic fibrosis lung. Microbial Genomics, 4 (8). doi: 10.1099/mgen.0.000194
Lutzky, Viviana P., Ratnatunga, Champa N., Smith, Daniel J., Kupz, Andreas, Doolan, Denise L., Reid, David W., Thomson, Rachel M., Bell, Scott C. and Miles, John J. (2018). Anomalies in T cell function are associated with individuals at risk of Mycobacterium abscessus complex infection. Frontiers in Immunology, 9 (June) 1319, 1319. doi: 10.3389/fimmu.2018.01319
Biomarkers: their role in CFTR modulator therapies from early development to the clinic
Bell, Scott C. and Wood, Michelle E. (2018). Biomarkers: their role in CFTR modulator therapies from early development to the clinic. American Journal of Respiratory and Critical Care Medicine, 197 (11), 1375-1376. doi: 10.1164/rccm.201801-0177ED
Optimism, opportunities, outcomes: the Australian Cystic Fibrosis Data Registry
Ahern, Susannah, Sims, Geoff, Earnest, Arul and Bell, Scott C. (2018). Optimism, opportunities, outcomes: the Australian Cystic Fibrosis Data Registry. Internal Medicine Journal, 48 (6), 721-723. doi: 10.1111/imj.13807
Inhaled corticosteroids for bronchiectasis (review)
Kapur, Nitin, Petsky, Helen L., Bell, Scott, Kolbe, John and Chang, Anne B. (2018). Inhaled corticosteroids for bronchiectasis (review). Cochrane Database of Systematic Reviews, 2018 (5) CD000996. doi: 10.1002/14651858.CD000996.pub3
Bronchiectasis: yet another systemic disease?
Geake, James and Bell, Scott C. (2018). Bronchiectasis: yet another systemic disease?. Respirology, 23 (9), 797-798. doi: 10.1111/resp.13322
Cystic fibrosis pathogens survive for extended periods within cough-generated droplet nuclei
Wood, Michelle E., Stockwell, Rebecca E., Johnson, Graham R., Ramsay, Kay A., Sherrard, Laura J., Kidd, Timothy J., Cheney, Joyce, Ballard, Emma L., O'Rourke, Peter, Jabbour, Nassib, Wainwright, Claire E., Knibbs, Luke D., Sly, Peter D., Morawska, Lidia and Bell, Scott C. (2018). Cystic fibrosis pathogens survive for extended periods within cough-generated droplet nuclei. Thorax, 74 (1), thoraxjnl-2018. doi: 10.1136/thoraxjnl-2018-211567
The experience of men and women with cystic fibrosis who have become a parent: a qualitative study
Jessup, Melanie, Li, Anne, Fulbrook, Paul and Bell, Scott (2018). The experience of men and women with cystic fibrosis who have become a parent: a qualitative study. Journal of Clinical Nursing, 27 (7-8), 1702-1712. doi: 10.1111/jocn.14229
ECFS best practice guidelines: the 2018 revision
Castellani, Carlo, Duff, Alistair J. A., Bell, Scott C., Heijerman, Harry G. M., Munck, Anne, Ratjen, Felix, Sermet-Gaudelus, Isabelle, Southern, Kevin W., Barben, Jurg, Flume, Patrick A., Hodková, Pavla, Kashirskaya, Nataliya, Kirszenbaum, Maya N., Madge, Sue, Oxley, Helen, Plant, Barry, Schwarzenberg, Sarah Jane, Smyth, Alan R., Taccetti, Giovanni, Wagner, Thomas O. F., Wolfe, Susan P. and Drevinek, Pavel (2018). ECFS best practice guidelines: the 2018 revision. Journal of Cystic Fibrosis, 17 (2), 153-178. doi: 10.1016/j.jcf.2018.02.006
Wood, Michelle E., Stockwell, Rebecca E., Johnson, Graham R., Ramsay, Kay A., Sherrard, Laura J., Jabbour, Nassib, Ballard, Emma, O'Rourke, Peter, Kidd, Timothy J., Wainwright, Claire E., Knibbs, Luke D., Sly, Peter D., Morawska, Lidia and Bell, Scott C. (2018). Face masks and cough etiquette reduce the cough aerosol concentration of Pseudomonas aeruginosa in people with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine, 197 (3), 338-355. doi: 10.1164/rccm.201707-1457OC
Differential expression of genes and receptors in monocytes from patients with cystic fibrosis
Tarique, Abdullah A., Sly, Peter D., Cardenas, Diana G., Luo, Lin, Stow, Jennifer L., Bell, Scott C., Wainwright, Claire E. and Fantino, Emmanuelle (2018). Differential expression of genes and receptors in monocytes from patients with cystic fibrosis. Journal of Cystic Fibrosis, 18 (3), 342-348. doi: 10.1016/j.jcf.2018.07.012
Lower airway microbiota for biomarker measurements of cystic fibrosis disease progression?
Sherrard, Laura J. and Bell, Scott C. (2018). Lower airway microbiota for biomarker measurements of cystic fibrosis disease progression?. Thorax, 73 (11), 1001-1003. doi: 10.1136/thoraxjnl-2018-212165
Tai, Anna S., Sherrard, Laura J., Kidd, Timothy J., Ramsay, Kay A., Buckley, Cameron, Syrmis, Melanie, Grimwood, Keith, Bell, Scott C. and Whiley, David M. (2017). Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis. BMC pulmonary medicine, 17 (1) 138, 1-10. doi: 10.1186/s12890-017-0482-7
Bell, Scott C. (2017). Early intervention of cystic fibrosis pulmonary exacerbations based on home monitoring eICE through the looking glass. American Journal of Respiratory and Critical Care Medicine, 196 (9), 1090-1092. doi: 10.1164/rccm.201706-1207ED
Learning's from the Editors Desk – 2017
Bell, Scott C., Castellani, Carlo and Flume, Patrick A. (2017). Learning's from the Editors Desk – 2017. Journal of Cystic Fibrosis, 16 (6), 645-646. doi: 10.1016/j.jcf.2017.10.001
The treatment of the pulmonary and extrapulmonary manifestations of cystic fibrosis
Chin, Melanie, Aaron, Shawn D. and Bell, Scott C. (2017). The treatment of the pulmonary and extrapulmonary manifestations of cystic fibrosis. Presse Medicale, 46 (6), E139-E164. doi: 10.1016/j.lpm.2016.11.030
Tropical Australia is a potential reservoir of non-tuberculous mycobacteria in cystic fibrosis
Sherrard, Laura J., Tay, George T., Butler, Claire A., Wood, Michelle E., Yerkovich, Stephanie, Ramsay, Kay A., Reid, David W., Moore, Vanessa L., Kidd, Timothy J. and Bell, Scott C. (2017). Tropical Australia is a potential reservoir of non-tuberculous mycobacteria in cystic fibrosis. European Respiratory Journal, 49 (5) 1700046, 1700046. doi: 10.1183/13993003.00046-2017
Sources and dynamics of fluorescent particles in hospitals
Pereira, M. L., Knibbs, L. D., He, C., Grzybowski, P., Johnson, G. R., Huffman, J. A., Bell, S. C., Wainwright, C. E., Matte, D. L., Dominski, F. H., Andrade, A. and Morawska, L. (2017). Sources and dynamics of fluorescent particles in hospitals. Indoor Air, 27 (5), 988-1000. doi: 10.1111/ina.12380
CFTR-dependent defect in alternatively-activated macrophages in cystic fibrosis
Tarique, Abdullah A., Sly, Peter D., Holt, Patrick G., Bosco, Anthony, Ware, Robert S., Logan, Jayden, Bell, Scott C., Wainwright, Claire E. and Fantino, Emmanuelle (2017). CFTR-dependent defect in alternatively-activated macrophages in cystic fibrosis. Journal of Cystic Fibrosis, 16 (4), 475-482. doi: 10.1016/j.jcf.2017.03.011
Viberg, Linda T., Sarovich, Derek S., Kidd, Timothy J., Geake, James B., Bell, Scott C., Currie, Bart J. and Price, Erin P. (2017). Within-host evolution of Burkholderia pseudomallei during chronic infection of seven Australasian cystic fibrosis patients. mBio, 8 (2) e00356-17, 1-17. doi: 10.1128/mBio.00356-17
Treatment decisions for MRSA in patients with cystic fibrosis (CF): When is enough, enough?
Bell, Scott C. and Flume, Patrick A. (2017). Treatment decisions for MRSA in patients with cystic fibrosis (CF): When is enough, enough?. Thorax, 72 (4), 297-299. doi: 10.1136/thoraxjnl-2016-209605
Bell, Scott, Peng, Huashan, Crapper, Liam, Kolobova, Ilaria, Maussion, Gilles, Vasuta, Cristina, Yerko, Volodymyr, Pan Wong, Tak and Ernst, Carl (2017). A rapid pipeline to model rare neurodevelopmental disorders with simultaneous CRISPR/Cas9 gene editing. Stem Cells Translational Medicine, 6 (3), 886-896. doi: 10.1002/sctm.16-0158
Sherrard, Laura J., Tai, Anna S., Wee, Bryan A., Ramsay, Kay A., Kidd, Timothy J., Ben Zakour, Nouri L., Whiley, David M., Beatson, Scott A. and Bell, Scott C. (2017). Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in cystic fibrosis. PLoS One, 12 (3) e0172179, e0172179.1-e0172179.15. doi: 10.1371/journal.pone.0172179
Implication of LRRC4C and DPP6 in neurodevelopmental disorders
Maussion, Gilles, Cruceanu, Cristiana, Rosenfeld, Jill A., Bell, Scott C., Jollant, Fabrice, Szatkiewicz, Jin, Collins, Ryan L., Hanscom, Carrie, Kolobova, Ilaria, de Champfleur, Nicolas Menjot, Blumenthal, Ian, Chiang, Colby, Ota, Vanessa, Hultman, Christina, O'Dushlaine, Colm, McCarroll, Steve, Alda, Martin, Jacquemont, Sebastien, Ordulu, Zehra, Marshall, Christian R., Carter, Melissa T., Shaffer, Lisa G., Sklar, Pamela, Girirajan, Santhosh, Morton, Cynthia C., Gusella, James F., Turecki, Gustavo, Stavropoulos, Dimitri J., Sullivan, Patrick F. ... Ernst, Carl (2017). Implication of LRRC4C and DPP6 in neurodevelopmental disorders. American Journal of Medical Genetics, Part A, 173 (2), 395-406. doi: 10.1002/ajmg.a.38021
Lumacaftor/ivacaftor treatment of patients with cystic fibrosis heterozygous for F508del-CFTR
Rowe, Steven M., McColley, Susanna A., Rietschel, Ernst, Li, Xiaolei, Bell, Scott C., Konstan, Michael W., Marigowda, Gautham, Waltz, David and Boyle, Michael P. (2017). Lumacaftor/ivacaftor treatment of patients with cystic fibrosis heterozygous for F508del-CFTR. Annals of the American Thoracic Society, 14 (2), 213-219. doi: 10.1513/AnnalsATS.201609-689OC
Clostridium difficile infection in cystic fibrosis: an uncommon but life-threatening complication
Piccolo, Francesco, Tai, Anna Sze, Ee, Hooi, Mulrennan, Siobhain, Bell, Scott and Ryan, Gerard (2017). Clostridium difficile infection in cystic fibrosis: an uncommon but life-threatening complication. Respirology Case Reports, 5 (1) e00204, e00204. doi: 10.1002/rcr2.204
Montgomery, Shaylyn H., Shamji, Colleen M., Yi, Grace S., Yarnold, Cynthia H., Head, Stephen J., Bell, Scott C. and Schwarz, Stephan K. W. (2017). Effect of Nerve Stimulation Use on the Success Rate of Ultrasound-Guided Subsartorial Saphenous Nerve Block A Randomized Controlled Trial. Regional Anesthesia and Pain Medicine, 42 (1), 25-31. doi: 10.1097/AAP.0000000000000522
Bell, Scott C., Castellani, Carlo and Flume, Patrick A. (2017). JCF - 2016. Journal of Cystic Fibrosis, 16 (1), 6-6. doi: 10.1016/j.jcf.2016.12.014
Limitations to providing adult cystic fibrosis care in Europe: results of a care centre survey
Madge, Susan, Bell, Scott C., Burgel, Pierre- Régis, De Rijcke, Karleen, Blasi, Francesco and Elborn, J. Stuart (2017). Limitations to providing adult cystic fibrosis care in Europe: results of a care centre survey. Journal of Cystic Fibrosis, 16 (1), 85-88. doi: 10.1016/j.jcf.2016.07.001
Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium
Bryant, Josephine M., Grogono, Dorothy M., Rodriguez-Rincon, Daniela, Everall, Isobel, Brown, Karen P., Moreno, Pablo, Verma, Deepshikha, Hill, Emily, Drijkoningen, Judith, Gilligan, Peter, Esther, Charles R., Noone, Peadar G., Giddings, Olivia, Bell, Scott C., Thomson, Rachel, Wainwright, Claire E., Coulter, Chris, Pandey, Sushil, Wood, Michelle E., Stockwell, Rebecca E., Ramsay, Kay A., Sherrard, Laura J., Kidd, Timothy J., Jabbour, Nassib, Johnson, Graham R., Knibbs, Luke D., Morawska, Lidia, Sly, Peter D., Jones, Andrew ... Floto, R. Andres (2016). Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium. Science, 354 (6313), 751-757. doi: 10.1126/science.aaf8156
Lesch-Nyhan syndrome: Models, theories, and therapies
Bell, Scott, Kolobova, Ilaria, Crapper, Liam and Ernst, Carl (2016). Lesch-Nyhan syndrome: Models, theories, and therapies. Molecular Syndromology, 7 (6), 302-311. doi: 10.1159/000449296
Standardy opieki Europejskiego Towarzystwa Mukowiscydozy: wytyczne i najlepsze praktyki
Smyth, Alan R., Bell, Scott C., Bojcin, Snezana, Bryon, Mandy, Duff, Alistair, Flume, Patrick, Kashirskaya, Nataliya, Munck, Anne, Ratjen, Felix, Schwarzenberg, Sarah Jane, Sermet-Gaudelus, Isabelle, Southern, Kevin W., Taccetti, Giovanni, Ullrich, Gerald and Wolfe, Sue (2016). Standardy opieki Europejskiego Towarzystwa Mukowiscydozy: wytyczne i najlepsze praktyki. Pediatria Polska, 91 (Supp.1), S30-S53. doi: 10.1016/j.pepo.2016.08.014
Ramsay, Kay A., Sandhu, Harpreet, Geake, James B., Ballard, Emma, O'Rourke, Peter, Wainwright, Claire E., Reid, David W., Kidd, Timothy J. and Bell, Scott C. (2016). The changing prevalence of pulmonary infection in adults with cystic fibrosis: a longitudinal analysis. Journal of Cystic Fibrosis, 16 (1), 70-77. doi: 10.1016/j.jcf.2016.07.010
Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study
Wells, J. Michael, Farris, Roopan F., Gosdin, Taylor A., Dransfield, Mark T., Wood, Michelle E., Bell, Scott C. and Rowe, Steven M. (2016). Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study. Lancet Respiratory Medicine, 4 (8), 636-645. doi: 10.1016/S2213-2600(16)30105-9
The role of anaerobic bacteria in the cystic fibrosis airway
Sherrard, Laura J., Bell, Scott C. and Tunney, Michael M. (2016). The role of anaerobic bacteria in the cystic fibrosis airway. Current Opinion in Pulmonary Medicine, 22 (6), 637-643. doi: 10.1097/MCP.0000000000000299
Johnson, Graham R., Knibbs, Luke D., Kidd, Timothy J., Wainwright, Claire E., Wood, Michelle E., Ramsay, Kay A., Bell, Scott C. and Morawska, Lidia (2016). A novel method and its application to measuring pathogen decay in bioaerosols from patients with respiratory disease. PLoS One, 11 (7) e0158763, e0158763. doi: 10.1371/journal.pone.0158763
Flume, Patrick A., VanDevanter, Donald R., Morgan, Elizabeth E., Dudley, Michael N., Loutit, Jeffery S., Bell, Scott C., Kerem, Eitan, Fischer, Rainald, Smyth, Alan R., Aaron, Shawn D., Conrad, Douglas, Geller, David E. and Elborn, J. Stuart (2016). A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients. Journal of Cystic Fibrosis, 15 (4), 495-502. doi: 10.1016/j.jcf.2015.12.004
Stephenson, Anne L. and Bell, Scott C. (2016). The cystic fibrosis foundation patient registry: Design and methods of a national observational disease registry. Annals of the American Thoracic Society, 13 (7), 1014-1015. doi: 10.1513/AnnalsATS.201604-250ED
Wood, Michelle E., Sherrard, Laura J., Ramsay, Kay A., Yerkovich, Stephanie T., Reid, David W., Kidd, Timothy J. and Bell, Scott C. (2016). Methicillin-resistant Staphylococcus aureus acquisition in healthcare workers with cystic fibrosis: a retrospective cross-sectional study. BMC Pulmonary Medicine, 16 (78) 78, 1-7. doi: 10.1186/s12890-016-0243-z
Merner, Nancy, Forgeot d'Arc, Baudouin, Bell, Scott C., Maussion, Gilles, Peng, Huashan, Gauthier, Julie, Crapper, Liam, Hamdan, Fadi F., Michaud, Jacques L., Mottron, Laurent, Rouleau, Guy A. and Ernst, Carl (2016). A de novo frameshift mutation in chromodomain helicase DNA-binding domain 8 (CHD8): A case report and literature review. American Journal of Medical Genetics Part A, 170 (5), 1225-1235. doi: 10.1002/ajmg.a.37566
High ambient temperature and risk of intestinal obstruction in cystic fibrosis
Ooi, Chee Y., Jeyaruban, Christina, Lau, Jasmine, Katz, Tamarah, Matson, Angela, Bell, Scott C., Adams, Susan E. and Krishnan, Usha (2016). High ambient temperature and risk of intestinal obstruction in cystic fibrosis. Journal of Paediatrics and Child Health, 52 (4), 430-435. doi: 10.1111/jpc.13096
Infection in cystic fibrosis: impact of the environment and climate
Ramsay, K. A., Stockwell, R. E., Bell, S. C. and Kidd, T. J. (2016). Infection in cystic fibrosis: impact of the environment and climate. Expert Review of Respiratory Medicine, 10 (5), 505-519. doi: 10.1586/17476348.2016.1162715
Stuart Elborn, J., Davies, Jane, Bell, Scott and Derichs, Nico (2016). The effect of CFTR modulation on the disease progression of cystic fibrosis in the era of precision medicine. Journal of Cystic Fibrosis, 15 (2). doi: 10.1016/j.jcf.2015.12.012
Pseudomonas aeruginosa antibiotic resistance in Australian cystic fibrosis centres
Smith, Daniel J., Ramsay, Kay A., Yerkovich, Stephanie T., Reid, David W., Wainwright, Claire E., Grimwood, Keith, Bell, Scott C. and Kidd, Timothy J. (2016). Pseudomonas aeruginosa antibiotic resistance in Australian cystic fibrosis centres. Respirology, 21 (2), 329-337. doi: 10.1111/resp.12714
Elborn, J. Stuart, Bell, Scott C., Madge, Susan L., Burgel, Pierre-Regis, Castellani, Carlo, Conway, Steven, De Rijcke, Karleen, Dembski, Birgit, Drevinek, Pavel, Heijerman, Harry G.M., Innes, J. Alistair, Lindblad, Anders, Marshall, Bruce, Olesen, Hanne V., Reimann, Andreas L., Solé, Ampara, Viviani, Laura, Wagner, Thomas O.F., Welte, Tobias and Blasi, Francesco (2016). Report of the European respiratory society/European cystic fibrosis society task force on the care of adults with cystic fibrosis. European Respiratory Journal, 47 (2), 420-428. doi: 10.1183/13993003.00592-2015
Infection in cystic fibrosis: impact of the environment and climate (vol 10, pg 505, 2016)
Ramsay, K. A., Stockwell, R. E. and Bell, S. C. (2016). Infection in cystic fibrosis: impact of the environment and climate (vol 10, pg 505, 2016). Expert Review of Respiratory Medicine, 10 (6), 713-713. doi: 10.1080/17476348.2016.1184473
Bell, Scott C., Hartl, Dominik and Flume, Patrick (2016). JCF-2015. Journal of Cystic Fibrosis, 15 (1). doi: 10.1016/S1569-1993(15)00319-7
Tai, Anna Sze, Bell, Scott Cameron, Kidd, Timothy James, Trembizki, Ella, Buckley, Cameron, Ramsay, Kay Annette, David, Michael, Wainwright, Claire Elizabeth, Grimwood, Keith and Whiley, David Mark (2015). Genotypic Diversity within a Single Pseudomonas aeruginosa Strain Commonly Shared by Australian Patients with Cystic Fibrosis. Plos One, 10 (12) e0144022, e0144022. doi: 10.1371/journal.pone.0144022
Geake, James B., Reid, David W., Currie, Bart J., Bell, Scott C., Bright-Thomas, Rowland, Dewar, Jane, Holden, Steve, Simmonds, Nicholas, Gyi, Khin, Kenna, Dervla, Waters, Valerie, Jackson, Mary, O'Sullivan, Brian, Taccetti, Giovanni, Kolbe, John, O'Carroll ,Mark, Campbell, Dee, Jaksic, Mirjana, Radhakrishna, Naghmeh, Kidd, Timothy J. and Flight, William (2015). An international, multicentre evaluation and description of Burkholderia pseudomallei infection in cystic fibrosis. BMC Pulmonary Medicine, 15 (1) 116. doi: 10.1186/s12890-015-0109-9
A new phase of CFTR treatment for cystic fibrosis?
Bell, Scott C. (2015). A new phase of CFTR treatment for cystic fibrosis?. The Lancet Respiratory Medicine, 3 (9) 203, 662-663. doi: 10.1016/S2213-2600(15)00282-9
Freschi, Luca, Jeukens, Julie, Kukavica-Ibrulj, Irene, Boyle, Brian, Dupont, Marie-Josee, Laroche, Jerome, Larose, Stephane, Maaroufi, Halim, Fothergill, Joanne L., Moore, Matthew, Winsor, Geoffrey L., Aaron, Shawn D., Barbeau, Jean, Bell, Scott C., Burns, Jane L., Camara, Miguel, Cantin, Andre, Charette, Steve J., Dewar, Ken, Deziel, Eric, Grimwood, Keith, Hancock, Robert E. W., Harrison, Joe J., Heebs, Stephan, Jelsbak, Lars, Jia, Baofeng, Kenna, Dervla T., Kidd, Timothy J., Klockgether, Jens ... Levesque, Roger C. (2015). Clinical utilization of genomics data produced by the international Pseudomonas aeruginosa consortium. Frontiers in Microbiology, 6 (SEP) 01036, 1-8. doi: 10.3389/fmicb.2015.01036
Kidd, Timothy J., Magalhaes, Ricardo J. Soares, Paynter, Stuart and Bell, Scott C. (2015). The social network of cystic fibrosis centre care and shared Pseudomonas aeruginosa strain infection: a cross-sectional analysis. The Lancet Respiratory Medicine, 3 (8), 640-650. doi: 10.1016/S2213-2600(15)00228-3
De Smet, Birgit., Mayo, Mark., Peeters, Charlotte., Zlosnik, James E.A., Spilker, Theodore., Hird, Trevor J., Li Puma, John J., Kidd, Timothy J., Kaestli, Mirjam., Ginther, Jennifer L., Wagner, David M., Keim, Paul., Bell, Scott C., Jacobs, Jan A., Currie, Bart J. and Vandamme, Peter. (2015). Burkholderia stagnalis sp. nov. and Burkholderia territorii sp. nov., two novel Burkholderia cepacia complex species from environmental and human sources. International Journal of Systematic and Evolutionary Microbiology, 65 (7), 2265-2271. doi: 10.1099/ijs.0.000251
Ratjen, Felix, Bell, Scott C., Rowe, Steven M., Goss, Christopher H., Quittner, Alexandra L. and Bush, Andrew (2015). Cystic fibrosis. Nature Reviews. Disease Primers, 1 (1) 15010 . doi: 10.1038/nrdp.2015.10
Tai, Anna S., Sidjabat, Hanna E., Kidd, Timothy J., Whiley, David M., Paterson, David L. and Bell, Scott C. (2015). Evaluation of phenotypic screening tests for carbapenemase production in Pseudomonas aeruginosa from patients with cystic fibrosis. Journal of Microbiological Methods, 111, 105-107. doi: 10.1016/j.mimet.2015.02.006
Jong, T., Geake, J., Yerkovich, S. and Bell, S. C. (2015). Idiosyncratic reactions are the most common cause of abnormal liver function tests in patients with cystic fibrosis. Internal Medicine Journal, 45 (4), 395-401. doi: 10.1111/imj.12707
Viberg, Linda T., Price, Erin P., Kidd, Timothy J., Bell, Scott C., Currie, Bart J. and Sarovich, Derek S. (2015). Whole-genome sequences of five Burkholderia pseudomallei isolates from australian cystic fibrosis patients. Genome Announcements, 3 (2) e00254-15. doi: 10.1128/genomeA.00254-15
Tai, Anna S., Kidd, Timothy J., Whiley, David M., Ramsay, Kay A., Buckley, Cameron, Bell, Scott C., The ACPinCF Investigator Group and David, Michael (2015). Molecular surveillance for carbapenemase genes in carbapenem-resistant Pseudomonas aeruginosa in Australian patients with cystic fibrosis. Pathology, 47 (2), 156-160. doi: 10.1097/PAT.0000000000000216
Chang, Anne B., Bell, Scott C., Torzillo, Paul J., King, Paul T., Maguire, Graeme P., Byrnes, Catherine A., Holland, Anne E., O’Mara, Peter, Grimwood, Keith, Alison, Jenny, Cull, Chris, Currie, Bart, Gardner, Inge, Holmes, Peter, Hunter, Cameron, Kolbe, John, Maclennan, Carolyn, McDonald, Malcolm, Morris, Peter, Nicolson, Caroline, Petsky, Helen, Pillarisetti, Naveen, Reynolds, Emma, Serisier, David, Thein, Frank, van Asperen, Peter, Voss, Lesley and Wong, Conroy (2015). Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand. Medical Journal of Australia, 202 (1), 21-24. doi: 10.5694/mja14.00287
Pseudomonas aeruginosa genotypes acquired by children with cystic fibrosis by age 5-years
Kidd, Timothy J., Ramsay, Kay A., Vidmar, Suzanna, Carlin, John B., Bell, Scott C., Wainwright, Claire E. and Grimwood, Keith (2015). Pseudomonas aeruginosa genotypes acquired by children with cystic fibrosis by age 5-years. Journal of Cystic Fibrosis, 14 (3), 361-369. doi: 10.1016/j.jcf.2014.12.007
Stuart Elborn, J., Geller, David E., Conrad, Douglas, Aaron, Shawn D., Smyth, Alan R., Fischer, Rainald, Kerem, Eitan, Bell, Scott C., Loutit, Jeffery S., Dudley, Michael N., Morgan, Elizabeth E., VanDevanter, Donald R. and Flume, Patrick A. (2015). A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patients. Journal of Cystic Fibrosis, 14 (4), 507-514. doi: 10.1016/j.jcf.2014.12.013
Future trends in cystic fibrosis demography in 34 European countries
Burgel, Pierre-Régis, Bellis, Gil, Olesen, Hanne V., Viviani, Laura, Zolin, Anna, Blasi, Francesco, Elborn, J. Stuart, Bell, Scott, Castellani, Carlo, Dembski, Birgit, Drevinek, Pavel, Heijerman, Harry, Innes, Alastair, Lindblad, Anders, Madge, Susan, De Rijcke, Karleen and Solé, Amparo (2015). Future trends in cystic fibrosis demography in 34 European countries. European Respiratory Journal, 46 (1), 133-141. doi: 10.1183/09031936.00196314
New pharmacological approaches for cystic fibrosis: Promises, progress, pitfalls
Bell, S.C., De Boeck, K. and Amaral, M.D. (2015). New pharmacological approaches for cystic fibrosis: Promises, progress, pitfalls. Pharmacology and Therapeutics, 145, 19-34. doi: 10.1016/j.pharmthera.2014.06.005
Dwyer, Tiffany J., Robbins, Lisel, Kelly, Patrick, Piper, Amanda J., Bell, Scott C. and Bye, Peter T.P. (2015). Non-invasive ventilation used as an adjunct to airway clearance treatments improves lung function during an acute exacerbation of cystic fibrosis: A randomised trial. Journal of Physiotherapy, 61 (3), 142-147. doi: 10.1016/j.jphys.2015.05.019
Bell, Scott C., Heijerman, Harry and Hartl, Dominik (2014). JCF - 2014 and beyond. Journal of Cystic Fibrosis, 13 (6), 610-611. doi: 10.1016/j.jcf.2014.09.009
Smith, Daniel J., Hill, Geoffrey R., Bell, Scott C. and Reid, David W. (2014). Reduced mucosal associated invariant T-cells are associated with increased disease severity and Pseudomonas aeruginosa infection in cystic fibrosis. PLoS ONE, 9 (10) e109891, 1-8. doi: 10.1371/journal.pone.0109891
Antimicrobial treatment of non-cystic fibrosis bronchiectasis
Grimwood, K., Bell, S.C. and Chang, A.B. (2014). Antimicrobial treatment of non-cystic fibrosis bronchiectasis. Expert Review of Anti-Infective Therapy, 12 (10), 1277-1296. doi: 10.1586/14787210.2014.952282
Smith, Daniel J., Badrick, Alison C., Zakrzewski, Martha, Krause, Lutz, Bell, Scott C., Anderson, Gregory J. and Reid, David W. (2014). Pyrosequencing reveals transient cystic fibrosis lung microbiome changes with intravenous antibiotics. European Respiratory Journal, 44 (4), 922-930. doi: 10.1183/09031936.00203013
Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis
Knibbs, Luke D., Johnson, Graham R., Kidd, Timothy J., Cheney, Joyce, Grimwood, Keith, Kattenbelt, Jacqueline A., O'Rourke, Peter K., Ramsay, Kay A., Sly, Peter D., Wainwright, Claire E., Wood, Michelle E., Morawska, Lidia and Bell, Scott C. (2014). Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis. Thorax, 69 (8), 740-745. doi: 10.1136/thoraxjnl-2014-205213
Syrmis, Melanie W., Kidd, Timothy J., Moser, Ralf J., Ramsay, Kay A., Gibson, Kristen M., Anuj, Snehal, Bell, Scott C., Wainwright, Claire E., Grimwood, Keith, Nissen, Michael, Sloots, Theo P. and Whiley, David M. (2014). A comparison of two informative SNP-based strategies for typing Pseudomonas aeruginosa isolates from patients with cystic fibrosis. BMC Infectious Diseases, 14 (1) 307, 307.1-307.8. doi: 10.1186/1471-2334-14-307
Elevated metal concentrations in the CF airway correlate with cellular injury and disease severity
Smith, Daniel J., Anderson, Gregory J., Bell, Scott C. and Reid, David W. (2014). Elevated metal concentrations in the CF airway correlate with cellular injury and disease severity. Journal of Cystic Fibrosis, 13 (3), 289-295. doi: 10.1016/j.jcf.2013.12.001
European Cystic Fibrosis Society standards of care: best practice guidelines
Smyth, A.R., Bell, S.C., Bojcin, S., Bryon, M., Duff, A., Flume, P., Kashirskaya, N., Munck, A., Ratjen, F., Schwarzenberg, S.J., Sermet-Gaudelus, I., Southern, K.W., Taccetti, G., Ullrich, G. and Wolfe, S. (2014). European Cystic Fibrosis Society standards of care: best practice guidelines. Journal of Cystic Fibrosis, 13 (S1), S23-S42. doi: 10.1016/j.jcf.2014.03.010
Smith, Corey, Gras, Stephanie, Brennan, Rebekah M., Bird, Nicola L., Valkenburg, Sophie A., Twist, Kelly-Anne, Burrows, Jacqueline M., Miles, John J., Chambers, Daniel, Bell, Scott, Campbell, Scott, Kedzierska, Katherine, Burrows, Scott R., Rossjohn, Jamie and Khanna, Rajiv (2014). Molecular imprint of exposure to naturally occurring genetic variants of human cytomegalovirus on the T cell repertoire. Scientific Reports, 4 (1) 3993, 3993.1-3993.10. doi: 10.1038/srep03993
Boyle, Michael P., Bell, Scott C., Konstan, Michael W., McColley, Susanna A., Rowe, Steven M., Rietschel, Ernst, Huang, Xiaohong, Waltz, David, Patel, Naimish R. and Rodman, David (2014). A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: A phase 2 randomised controlled trial. The Lancet Respiratory Medicine, 2 (7), 527-538. doi: 10.1016/S2213-2600(14)70132-8
Challenges of providing care to adults with cystic fibrosis
Bell, Scott C. and Reid, David W. (2014). Challenges of providing care to adults with cystic fibrosis. European Respiratory Monograph, 64 (64), 286-303. doi: 10.1183/1025448x.10010513
Pregnancy and cystic fibrosis: approach to contemporary management
Geake, James, Tay, George, Callaway, Leonie and Bell, Scott C. (2014). Pregnancy and cystic fibrosis: approach to contemporary management. Obstetric Medicine, 7 (4), 147-155. doi: 10.1177/1753495X14554022
Change in the executive editorial team at JCF
Bell, Scott, Hartl, Dominik and Heijerman, Harry (2013). Change in the executive editorial team at JCF. Journal of Cystic Fibrosis, 12 (6), 545-546. doi: 10.1016/j.jcf.2013.10.006
Ramsay, Kay A., Butler, Claire A., Paynter, Stuart, Ware, Robert S., Kidd, Timothy J., Wainwright, Claire E. and Bell, Scott C. (2013). Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosis. Journal of Clinical Microbiology, 51 (12), 3975-3980. doi: 10.1128/JCM.01360-13
Ivacaftor in severe cystic fibrosis lung disease and a G551D mutation
Wood, Michelle E., Smith, Daniel J., Reid, David W., Masel, Philip J., France, Megan W. and Bell, Scott C. (2013). Ivacaftor in severe cystic fibrosis lung disease and a G551D mutation. Respirology Case Reports, 1 (2), 52-54. doi: 10.1002/rcr2.27
Within-host evolution of Burkholderia pseudomallei over a twelve-year chronic carriage infection
Price E.P., Sarovich D.S., Mayo M., Tuanyok A., Drees K.P., Kaestli M., Beckstrom-Sternberg S.M., Babic-Sternberg J.S., Kidd T.J., Bell S.C., Keim P., Pearson T. and Currie B.J. (2013). Within-host evolution of Burkholderia pseudomallei over a twelve-year chronic carriage infection. mBio, 4 (4) e00388-13, e00388-13.1-e00388-13.11. doi: 10.1128/mBio.00388-13
Syrmis, Melanie W., Moser, Ralf J., Kidd, Timothy J., Hunt, Priscilla, Ramsay, Kay A., Bell, Scott C., Wainwright, Claire E., Grimwood, Keith, Nissen, Michael D., Sloots, Theo P. and Whiley, David M. (2013). High-throughput single-nucleotide polymorphism-based typing of shared Pseudomonas aeruginosa strains in cystic fibrosis patients using the Sequenom iPLEX platform. Journal of Medical Microbiology, 62 (5), 734-740. doi: 10.1099/jmm.0.055905-0
ICU outcomes in cystic fibrosis following invasive ventilation
Reid, David W. and Bell, Scott C. (2013). ICU outcomes in cystic fibrosis following invasive ventilation. Respirology, 18 (4), 585-586. doi: 10.1111/resp.12077
Management of comorbidities in older patients with cystic fibrosis
Plant, Barry J, Goss, Christopher H, Plant, William D and Bell, Scott C (2013). Management of comorbidities in older patients with cystic fibrosis. The Lancet Respiratory Medicine, 1 (2), 164-174. doi: 10.1016/S2213-2600(13)70025-0
Bell, Sara C., Alford, Ross A., Garland, Stephen, Padilla, Gabriel and Thomas, Annette D. (2013). Screening bacterial metabolites for inhibitory effects against Batrachochytrium dendrobatidis using a spectrophotometric assay. Diseases of Aquatic Organisms, 103 (1), 77-+. doi: 10.3354/dao02560
Aztreonam for inhalation solution, challenges to drug approval and integration into CF care
Goss, Christopher H. and Bell, Scott C. (2013). Aztreonam for inhalation solution, challenges to drug approval and integration into CF care. Journal of Cystic Fibrosis, 12 (2), 99-101. doi: 10.1016/j.jcf.2012.08.006
Geographical differences in first acquisition of Pseudomonas aeruginosa in cystic fibrosis
Ranganathan, Sarath C., Skoric, Billy, Ramsay, Kay A., Carzino, Rosemary, Gibson, Anne-Marie, Hart, Emily, Harrison, Jo, Bell, Scott C. and Kidd, Timothy J. (2013). Geographical differences in first acquisition of Pseudomonas aeruginosa in cystic fibrosis. Annals of the American Thoracic Society, 10 (2), 108-114. doi: 10.1513/AnnalsATS.201209-077OC
Sputum neutrophils in cystic fibrosis patients display a reduced respiratory burst
Houston, Neralee, Stewart, Niall, Smith, Daniel S., Bell, Scott C., Champion, Alan C. and Reid, David W. (2013). Sputum neutrophils in cystic fibrosis patients display a reduced respiratory burst. Journal of Cystic Fibrosis, 12 (4), 352-362. doi: 10.1016/j.jcf.2012.11.004
Smith, D.J., Anderson, G.J., Lamont, I.L., Masel, P., Bell, S.C. and Reid, D.W. (2012). Accurate assessment of systemic iron status in cystic fibrosis will avoid the hazards of inappropriate iron supplementation. Journal of Cystic Fibrosis, 12 (3), 303-304. doi: 10.1016/j.jcf.2012.10.001
Butler, Claire Ann and Bell, Scott Cameron (2012). New insights into gene-specific management in cystic fibrosis from the 2012 European Cystic Fibrosis Conference. Expert Review of Respiratory Medicine, 6 (5), 499-501. doi: 10.1586/ERS.12.52
Kidd, Timothy J., Richie, Stephen R., Ramsay, Kay A., Grimwood, Keith, Bell, Scott C. and Rainey, Paul B. (2012). Pseudomonas aeruginosa exhibits frequent recombination, but only a limited association between genotype and ecological setting. PLoS One, 7 (9) e44199, e44199.1-e44199.14. doi: 10.1371/journal.pone.0044199
Shared pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres
Kidd, Timothy J., Ramsay, Kay A., Hu, Honghua, Marks, Guy B., Wainwright, Claire E., Bye, Peter T., Elkins, Mark R., Robinson, Philip J., Rose, Barbara R., Wilson, John W., Grimwood, Keith, Bell, Scott C., ACPinCF Investigator Group, Serisier, David J. and Smith, Daniel J. (2012). Shared pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres. European Respiratory Journal, 41 (5), 1091-1100. doi: 10.1183/09031936.00060512
The risk of airborne influenza transmission in passenger cars
Knibbs, L. D., Morawska, L. and Bell, S. C. (2012). The risk of airborne influenza transmission in passenger cars. Epidemiology and Infection, 140 (3), 474-478. doi: 10.1017/S0950268811000835
Comparison of the US and Australian Cystic Fibrosis Registries: The impact of newborn screening
Martin, Bradley, Schechter, Michael S., Jaffe, Adam, Cooper, Peter, Bell, Scott C. and Ranganathan, Sarath (2012). Comparison of the US and Australian Cystic Fibrosis Registries: The impact of newborn screening. Pediatrics, 129 (2), E348-E355. doi: 10.1542/peds.2011-0567
Knibbs, Luke D., Morawska, Lidia, Bell, Scott C. and Grzybowski, Piotr (2011). Room ventilation and the risk of airborne infection transmission in 3 health care settings within a large teaching hospital. American Journal of Infection Control, 39 (10), 866-872. doi: 10.1016/j.ajic.2011.02.014
A CFTR potentiator in patients with Cystic Fibrosis and the G551D Mutation
Ramsey, Bonnie W., Davies, Jane, McElvaney, N. Gerard, Tullis, Elizabeth, Bell, Scott C., Drevinek, Pavel, Griese, Matthias, McKone, Edward F., Wainwright, Claire E., Konstan, Michael W., Moss, Richard, Ratjen, Felix, Sermet-Gaudelus, Isabelle, Rowe, Steven M., Dong, Qunming, Rodriguez, Sally, Yen, Karl, Ordonez, Claudia and Elborn, J. Stuart (2011). A CFTR potentiator in patients with Cystic Fibrosis and the G551D Mutation. New England Journal of Medicine, 365 (18), 1663-1672. doi: 10.1056/NEJMoa1105185
Effect of temperature on cystic fibrosis lung disease and infections: A replicated cohort study
Collaco, Joseph M., McGready, John, Green, Deanna M., Naughton, Kathleen M., Watson, Christopher P., Shields, Timothy, Bell, Scott C., Wainwright, Claire E. and Cutting, Garry R. (2011). Effect of temperature on cystic fibrosis lung disease and infections: A replicated cohort study. PLoS One, 6 (11) e27784, 1-7. doi: 10.1371/journal.pone.0027784
Treatment of pulmonary exacerbations in cystic fibrosis
Smith, Daniel J., Reid, David W. and Bell, Scott C. (2011). Treatment of pulmonary exacerbations in cystic fibrosis. Therapy, 8 (6), 623-643. doi: 10.2217/thy.11.77
Cystic fibrosis in Australia, 2009: Results from a data registry
Bell, Scott C., Bye, Peter T.P., Cooper, Peter J., Martin, A. James, McKay, Karen O., Robinson, Phillip J., Ryan, Gerard F. and Sims, Geoff C. (2011). Cystic fibrosis in Australia, 2009: Results from a data registry. Medical Journal of Australia, 195 (7), 396-400. doi: 10.5694/mja11.10719
Anuj, S. N., Whiley, D. M., Kidd, T. J., Ramsay, K. A., Bell, S. C., Syrmis, M. W., Grimwood, K., Wainwright, C. E., Nissen, M. D. and Sloots, T. P. (2011). Rapid single-nucleotide polymorphism-based identification of clonal Pseudomonas aeruginosa isolates from patients with cystic fibrosis by the use of real-time PCR and high-resolution melting curve analysis. Clinical Microbiology and Infection, 17 (9), 1403-1408. doi: 10.1111/j.1469-0691.2010.03439.x
Clonal complex Pseudomonas aeruginosa in horses
Kidd, Timothy J., Gibson, Justine S., Moss, Susan, Greer, Ristan M., Cobbold, Rowland N., Wright, John D., Ramsay, Kay A., Grimwood, Keith and Bell, Scott C. (2011). Clonal complex Pseudomonas aeruginosa in horses. Veterinary Microbiology, 149 (3-4), 508-512. doi: 10.1016/j.vetmic.2010.11.030
Transition of adolescents with cystic fibrosis from paediatric to adult care
Towns, Susan Joy and Bell, Scott Cameron (2011). Transition of adolescents with cystic fibrosis from paediatric to adult care. Clinical Respiratory Journal, 5 (2), 64-75. doi: 10.1111/j.1752-699X.2010.00226.x
Kidd, Timothy J., Grimwood, Keith, Ramsay, Kay A., Rainey, Paul B. and Bell, Scott C. (2011). Comparison of three molecular techniques for typing pseudomonas aeruginosa isolates in sputum samples from patients with cystic fibrosis. Journal of Clinical Microbiology, 49 (1), 263-268. doi: 10.1128/JCM.01421-10
Kuys, Suzanne S., Hall, Kathleen, Peasey, Maureen, Wood, Michelle, Cobb, Robyn and Bell, Scott C. (2011). Gaming console exercise and cycle or treadmill exercise provide similar cardiovascular demand in adults with cystic fibrosis: A randomised cross-over trial. Journal of Physiotherapy, 57 (1), 35-40. doi: 10.1016/S1836-9553(11)70005-4
Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy
Lewindon, Peter J., Shepherd, Ross W., Walsh, Meagan J., Greer, Ristan M., Williamson, Richard, Pereria, Tamara N., Frawley, Kieran, Bell, Scott C., Smith, Jeffery L. and Ramm, Grant A. (2011). Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy. Hepatology, 53 (1), 193-201. doi: 10.1002/hep.24014
Smith, Daniel, Reid, David, Slaughter, Richard, Masel, Philip, Tai, Anna and Bell, Scott (2011). Superior vena cava obstruction due to total implantable venous access devices in cystic fibrosis: Case series and review. Respiratory Medicine CME, 4 (3), 99-104. doi: 10.1016/j.rmedc.2010.12.005
Chang, AB, Bell, SC, Byrnes, CA, Grimwood, K, Holmes, PW, King, PT, Kolbe, J, Landau, LI, Maguire, GP, McDonald, MI, Reid, DW, Thien, FC and Torzillo, PJ (2010). Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand. Medical Journal of Australia, 193 (6), 356-365. doi: 10.5694/j.1326-5377.2010.tb03949.x
Exercise testing in patients with cystic fibrosis: Why and which?
Bell, Scott C. and Morris, Norman R. (2010). Exercise testing in patients with cystic fibrosis: Why and which?. Journal of Cystic Fibrosis, 9 (5), 299-301. doi: 10.1016/j.jcf.2010.05.005
France, Megan W., Tai, Szeanna, Masel, Phillip J., Moore, Vanessa L., McMahon, Tracy L., Ritchie, Alexander J. and Bell, Scott C. (2010). The month of July: an early experience with pandemic influenza A (H1N1) in adults with cystic fibrosis. BMC Pulmonary Medicine, 10 (1) 8. doi: 10.1186/1471-2466-10-8
Tiller, Rebekah V, Gee, Jay E., Lonsway, David R., Gribble, Sonali, Bell, Scott C., Jennison, Amy V., Bates, John, Coulter, Chris, Hoffmaster, Alex R. and De, Barun K. (2010). Identification of an unusual Brucella strain (BO2) from a lung biopsy in a 52 year-old patient with chronic destructive pneumonia. BMC Microbiology, 10 (Article number 23) 23, 1-11. doi: 10.1186/1471-2180-10-23
Wainwright, C. E., France, M. W., O'Rourke, P., Anuj, S., Kidd, T. J., Nissen, M. D., Sloots, T. P., Coulter, C., Ristovski, Z., Hargreaves, M., Rose, B. R., Harbour, C., Bell, SC and Fennelly, KP (2009). Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis.. Thorax, 64 (11), 926-931. doi: 10.1136/thx.2008.112466
Barraclough, Katherine A., O'Connor, Annette, Bell, Scott C., Freitag, Andreas, Bye, Peter, Jeanneret, Alphonse, Berthiaume, Yves, Brown, Neil, Wilcox, Pearce, Ryan, Gerard, Brager, Nancy, Rabin, Harvey, Morrison, Nancy, Gibson, Peter, Jackson, Mary, Paterson, Nigel, Middleton, Peter and Aaron, Shawn D. (2009). Randomized trial of a decision aid for patients with cystic fibrosis considering lung transplantation. American Journal of Respiratory and Critical Care Medicine, 180 (8), 761-768. doi: 10.1164/rccm.200903-0421OC
Wynn, Katherine K., Crough, Tania, Campbell, Scott, McNeil, Keith, Galbraith, Andrew, Moss, Denis J., Silins, Sharon L., Bell, Scott and Khanna, Rajiv (2009). Narrowing of T-cell receptor beta variable repertoire during symptomatic herpesvirus infection in transplant patients. Immunology and Cell Biology, 88 (2), 125-135. doi: 10.1038/icb.2009.74
Genetic Modifiers of Liver Disease in Cystic Fibrosis
Jaclyn R. Bartlett, Kenneth J. Friedman, Simon C. Ling, Rhonda G. Pace, Scott C. Bell, Billy Bourke, Giuseppe CAstaldo, Carlo Castellani, Marco Cipolli, Carla Colombo, John L. Colombo, Dominique Debray, Adriana Fernandez, Florence Lacaille, Milan Macek Jr., Marion Rowland, Francesco Salvatore, Christopher J. Taylor, Claire Wainwright, Michael Wilschanski, Dana Zemkova, William B. Hannah, M. James Phillips, Mary Corey, Julian Zielenski, Ruslan Dorfman, Yunfei Wang, Fei Zou, Lawrence M. Silverman ... Michael R. Knowles (2009). Genetic Modifiers of Liver Disease in Cystic Fibrosis. JAMA, 302 (10), 1076-1083. doi: 10.1001/jama.2009.1295
Kidd, TJ, Marks, GB, Bye, PTP, Wainwright, CE, Robinson, PJ, Rose, BR, Harbour, C and Bell, SC (2009). Multi-centre research in Australia: Analysis of a recent National Health and Medical Research Council-funded project. RESPIROLOGY, 14 (7), 1051-1055. doi: 10.1111/j.1440-1843.2009.01595.x
Soulsby, N., Bell, S., Greville, H. and Doecke, C. (2009). Intravenous aminoglycoside usage and monitoring of patients with cystic fibrosis in Australia. What's new?. Internal Medicine Journal, 39 (8), 527-531. doi: 10.1111/j.1445-5994.2008.01787.x
Low rates of Pseudomonas aeruginosa misidentification in isolates from Cystic Fibrosis patients.
Kidd, Timothy J., Ramsay, Kay A., Hu, Honghua Hu, Bye, Peter T. P., Elkins, Mark R., Grimwood, Keith, Harbour, Colin, Marks, Guy B., Nissen, Michael D., Robinson, Phillip J., Rose, Barbara R., Sloots, Theo P., Wainwright, Claire E., Bell, Scott C. and ACPinCF Investigators (2009). Low rates of Pseudomonas aeruginosa misidentification in isolates from Cystic Fibrosis patients.. Journal of Clinical Microbiology, 47 (5), 1503-1509. doi: 10.1128/JCM.00014-09
Manos, Jim, Arthur, Jonathan, Rose, Barbara, Bell, Scott, Tingpej, Pholawat, Hu, Honghua, Webb, Jeremy, Kjelleberg, Staffan, Gorrell, Mark Douglas, Bye, Peter and Harbour, Colin (2009). Gene expression characteristics of a cystic fibrosis epidemic strain of Pseydomonas aeruginosa during biofilm and planktonic growth. FEMS Microbiology Letters, 292 (1), 107-114. doi: 10.1111/j.1574-6968.2008.01472.x
Reid, D. W. and Bell, S. C. (2009). Sugar sweet and deadly?. Microbiology, 155 (3), 665-666. doi: 10.1099/mic.0.024752-0
Death after lung transplantation in cystic fibrosis patients infected with Burkholderia cepacia
Hopkins, P. M., Kidd, T. J., Coulter, C., Feather, I. H., Derrington, P. and Bell, S. C. (2009). Death after lung transplantation in cystic fibrosis patients infected with Burkholderia cepacia. American Journal of Respiratory and Critical Care Medicine, 179 (3), 257-258. doi: 10.1164/ajrccm.179.3.257
Anuj, Snehal N., Whiley, David M., Kidd, Timothy J., Bell, Scott C., Wainwright, Claire E., Nissen, Michael D. and Sloots, Theo P. (2009). Identification of Pseudomonas aeruginosa by a duplex real-time polymerase chain reaction assay targeting the ecfX and the gyrB genes. Diagnostic Microbiology And Infectious Disease, 63 (2), 127-131. doi: 10.1016/j.diagmicrobio.2008.09.018
Inhaled steroids for bronchiectasis
Kapur, Nitin, Bell, Scott, Kolbe, John and Chang, Anne B. (2009). Inhaled steroids for bronchiectasis. Cochrane Database of Systematic Reviews (1) CD000996, CD000996.1-CD000996.29. doi: 10.1002/14651858.CD000996.pub2
Neutrophils in cystic fibrosis
Downey, D. G., Bell, S. C. and Elborn, J. S. (2009). Neutrophils in cystic fibrosis. Thorax, 64 (1), 81-88. doi: 10.1136/thx.2007.082388
Syrmis, Melanie, Bell, Scott, Bye, Peter, Coulter, Chris, Harbour, Colin, Iredell, Jon, Kidd, Tim, O'Carroll, Mark, Rose, Barbara, Wainwright, Claire, Sloots, Theo and Nissen, Michael (2008). High prevalence of a class 1 integron-associated aadB gene cassette in Pseudomonas aeruginosa isolates from an Australian cystic fibrosis patient population. Pathology, 40 (5), 524-525. doi: 10.1080/00313020802197921
Kidd, Timothy J., Douglas, Joel M., Bergh, Haakon A., Coulter, Chris and Bell, Scott C. (2008). Burkholderia cepacia complex epidemiology in persons with cystic fibrosis from Australia and New Zealand. Research in Microbiology, 159 (3), 194-199. doi: 10.1016/j.resmic.2008.01.001
Crough, Tania, Fazou, Chrysa, Weiss, Julissa, Campbell, Scott, Davenport, Miles P., Bell, Scott C., Galbraith, Andrew, McNeil, Keith and Khanna, Rajiv (2007). Symptomatic and asymptomatic viral recrudescence in solid-organ transplant recipients and its relationship with the antigen-specific CD8+ T-cell response. Journal of Virology, 81 (20), 11538-11542. doi: 10.1128/JVI.00581-07
Daily versus weekly azithromycin in cystic fibrosis patients.
McCormack, J. G., Bell, S. C., Senini, S., Walmsley, K., Patel, K., Wainwright, C., Serisier, D., Harris, M. and Bowler, S. (2007). Daily versus weekly azithromycin in cystic fibrosis patients.. European Respiratory Journal, 30 (3), 487-495. doi: 10.1183/09031936.00163306
Exacerbations in cystic fibrosis: 2. Prevention
Bell, S. C. and Robinson, P. J. (2007). Exacerbations in cystic fibrosis: 2. Prevention. Thorax, 62 (8), 723-732. doi: 10.1136/thx.2006.060897
Beta-lactam allergy in adults with cystic fibrosis
Burrows, Judith A., Nissen, Lisa M., Kirkpatrick, Carl M. J. and Bell, Scott. C. (2007). Beta-lactam allergy in adults with cystic fibrosis. Journal of Cystic Fibrosis, 6 (4), 297-303. doi: 10.1016/j.jcf.2006.11.001
Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON®-CMV
Walker, S., Fazou, C., Crough, T., Holdsworth, R., Kiely, P., Veale, M., Bell, S. C., Gailbraith, A. J., McNeil, K., Jones, S. and Khanna, R. (2007). Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON®-CMV. Transplant Infectious Disease, 9 (2), 165-170. doi: 10.1111/j.1399-3062.2006.00199.x
Tingpej, Pholawat, Smith, Lucas, Rose, Barbara, Zhu, Hua, Conibear, Tim, Al Nassafi, Khaled, Manos, Jim, Elkins, Mark, Bye, Peter, Willcox, Mark, Bell, Scott, Wainwright, Claire and Harbour, Colin (2007). Phenotypic characterization of clonal and nonclonal Psuedomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis. Journal of Clinical Microbiology, 45 (6), 1697-1704. doi: 10.1128/JCM.02364-06
Hennig, Stefanie, Waterhouse, Timothy H., Bell, Scott C., France, Megan, Wainwright, Claire E., Miller, Hugh, Charles, Bruce G. and Duffull, Stephen B. (2007). A D-optimal designed population pharmacokinetic study of oral itraconazole in adult cystic fibrosis patients. British Journal of Clinical Pharmacology, 63 (4), 438-450. doi: 10.1111/j.1365-2125.2006.02778.x
Pulmonary exacerbations in cystic fibrosis and bronchiectasis
Elborn, J. S. and Bell, S. C. (2007). Pulmonary exacerbations in cystic fibrosis and bronchiectasis. Thorax, 62 (4), 288-290. doi: 10.1136/thx.2006.065664
Gene-environmental interaction in asthma
Yang, Ian A., Savarimuthu, Santiyagu, Kim, Samuel T., Holloway, John W., Bell, Scott C. and Fong, Kwun M. (2007). Gene-environmental interaction in asthma. Current Opinion in Allergy & Clinical Immunology, 7 (1), 75-82. doi: 10.1097/ACI.0b013e328012ce39
Protease IV production in Pseudomonas aeruginosa from the lungs of adults with cystic fibrosis
Smith, Lucas, Rose, Barbara, Tingpej, Pholawat, Zhu, Hua, Conibear, Tim, Manos, Jim, Bye, Peter, Elkins, Mark, Willcox, Mark, Bell, Scoot, Wainwright, Claire and Harbour, Colin (2006). Protease IV production in Pseudomonas aeruginosa from the lungs of adults with cystic fibrosis. Journal of Medical Microbiology, 55 (12), 1641-1644. doi: 10.1099/jmm.0.46845-0
Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis
Buntain, H. M., Schluter, P. J., Bell, S. C., Greer, R. M., Wong, J. C. H., Batch, J., Lewindon, P. and Wainwright, C. E. (2006). Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis. Thorax, 61 (2), 146-154. doi: 10.1136/thx.2005.046516
Kidd, T. J., Coulter, C. and Bell, S. C. (2006). Epidemiological analysis of methicillin-resistant Staphylococcus aureus isolates from adult patients with cystic fibrosis. Infection Control and Hospital Epidemiology, 27 (2), 201-203. doi: 10.1086/501173
Hennig, S., Wainwright, C. E., Bell, S. C., Miller, H., Friberg, L. E. and Charles, B. G. (2006). Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients. Clinical Pharmacokinetics, 45 (11), 1099-1114. doi: 10.2165/00003088-200645110-00004
Block, J. K., Vandemheen, K. L., Tullis, E., Fergusson, D., Doucette, S., Haase, D., Berthiaume, Y., Brown, N., Wilcox, P., Bye, P., Bell, S., Noseworthy, M., Pedder, L., Freitag, A. and Paterson, N. (2006). Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria. Thorax, 61 (11), 969-974. doi: 10.1136/thx.2006.061366
Hill, Dominic, Rose, Barbara, Pajkos, Aniko, Robinson, Michael, Bye, Peter, Bell, Scott C., Elkins, Mark, Thompson, Barbara, MacLeod, Colin, Aaron, Shawn D. and Harbour, Colin (2005). Antibiotic susceptibilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions. Journal of Clinical Microbiology, 43 (10), 5085-5090. doi: 10.1128/JCM.43.10.5085-5090.2005
MRSA eradication in a health care worker with cystic fibrosis; re-emergence or re-infection?
Downey, D. G., Kidd, T. J., Coulter, C. and Bell, S. C. (2005). MRSA eradication in a health care worker with cystic fibrosis; re-emergence or re-infection?. Journal of Cystic Fibrosis, 4 (3), 205-207. doi: 10.1016/j.jcf.2005.05.014
Buntain, Helen M., Greer, Ristan M., Wong, Joseph C.H., Schluter, Philip J., Batch, Jennifer, Lewindon, Peter, Bell, Scott C. and Wainwright, Claire E. (2005). Pubertal development and its influences on bone mineral density in Australian children and adolescents with cystic fibrosis. Journal of Paediatrics And Child Health, 41 (7), 317-322. doi: 10.1111/j.1440-1754.2005.00635.x
Has the time come to prescribe azithromycin in cystic fibrosis patients?
McCormack, J. G. and Bell, S. C. (2005). Has the time come to prescribe azithromycin in cystic fibrosis patients?. Internal Medicine Journal, 35 (2), 73-74. doi: 10.1111/j.1445-5994.2004.00762.x
Clinical presentation of metabolic alkalosis in an adult patient with cystic fibrosis
Sweetser, Lisel J., Douglas, James A., Riha, Renata L. and Bell, Scott C. (2005). Clinical presentation of metabolic alkalosis in an adult patient with cystic fibrosis. Respirology, 10 (2), 254-256. doi: 10.1111/j.1440-1843.2005.00650.x
Aaron, Shawn D., Vandemheen, Katherine L., Ferris, Wendy, Fergusson, Dean, Tullis, Elizabeth, Haase, David, Berthiaume, Yves, Brown, Neil, Wilcox, Pearce, Yozghatlian, Veronica, Bye, Peter, Bell, Scott, Chan, Francis, Rose, Barbara, Jeanneret, Alphonse, Stephenson, Anne, Noseworthy, Mary, Freitag, Andreas, Paterson, Nigel, Doucette, Steve, Harbour, Colin, Ruel, Michel and MacDonald, Noni (2005). Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multi-resistant bacteria: A randomised, double-blind, controlled clinical trial. The Lancet, 366 (9484), 463-471. doi: 10.1016/S0140-6736(05)67060-2
Bell, S. C., Senini, S. L. and McCormack, J. G. (2005). Macrolides in cystic fibrosis. Chronic Respiratory Disease, 2 (2), 85-98. doi: 10.1191/1479972305cd066rs
Garske, L. A., Beatson, S. A., Leech, A. J., Walsh, S. L. and Bell, S. C. (2004). Sub-inhibitory concentrations of ceftazidime and tobramycin reduce the quorum sensing signals of Pseudomonas aeruginosa. Pathology, 36 (6), 571-575. doi: 10.1080/00313020400011300
Syrmis, Melanie W., O'Carroll, Mark R., Sloots, Theo P., Coulter, Chris, Wainwright, Claire E., Bell, Scott C. and Nissen, Michael D. (2004). Rapid genotyping of Pseudomonas aeruginosa isolates harboured by adult and paediatric patients with cystic fibrosis using repetitive-element-based PCR assays. Journal of Medical Microbiology, 53 (11), 1089-1096. doi: 10.1099/jmm.0.45611-0
Vitamin A levels in patients with CF are influenced by the inflammatory response
Greer, Ristan M., Buntain, Helen M., Lewindon, Peter J., Wainwright, Claire E., Potter, Julia M., Wong, Joseph C., Francis, Paul W., Batch, Jennifer A. and Bell, Scott C. (2004). Vitamin A levels in patients with CF are influenced by the inflammatory response. Journal of Cystic Fibrosis, 3 (3), 143-149. doi: 10.1016/j.jcf.2004.04.003
Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units
O'Carroll, M. R., Syrmis, M. W., Wainwright, C. E., Greer, R. M., Mitchell, P., Coulter, C., Sloots, T. P., Nissen, M. D. and Bell, S. C. (2004). Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units. European Respiratory Journal, 24 (1), 101-106. doi: 10.1183/09031936.04.00122903
Garske, L. A., Kidd, T. J., Gan, R., Bunting, J. P., Franks, C. A., Coulter, C., Masel, P. J. and Bell, S. C. (2004). Rifampicin and sodium fusidate reduces the frequency of methicillin-resistant Staphylococcus aureus (MRSA) isolation in adults with cystic fibrosis and chronic MRSA infection. Journal of Hospital Infection, 56 (3), 208-214. doi: 10.1016/j.jhin.2003.12.003
Buntain, HM, Greer, RM, Schluter, PJ, Wong, JCH, Batch, JA, Potter, JM, Lewindon, PJ, Powell, E, Wainwright, CE and Bell, SC (2004). Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study. Thorax, 59 (2), 149-155. doi: 10.1136/thorax.2003.006726
'Iron lung': Distinctive bronchoscopic features of acute iron tablet aspiration
Kim, Samuel T., Kaisar, Omar M., Clarke, Belinda E., Vandenburg, Russell A., Allen, David H., Bell, Scott C. and Fong, Kwun M. (2003). 'Iron lung': Distinctive bronchoscopic features of acute iron tablet aspiration. Respirology, 8 (4), 541-543. doi: 10.1046/j.1440-1843.2003.00506.x
Burkholderia pseudomallei: Another emerging pathogen in cystic fibrosis
O'Carroll, M. R., Kidd, T. J., Coulter, C., Smith, H. V., Rose, B. R., Harbour, C. and Bell, S. C. (2003). Burkholderia pseudomallei: Another emerging pathogen in cystic fibrosis. Thorax, 58 (12), 1087-1091. doi: 10.1136/thorax.58.12.1087
Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics
Armstrong, David, Bell, Scott, Robinson, Michael, Bye, Peter, Rose, Barbara, Harbour, Colin, Lee, Crystal, Service, Helen, Nissen, Michael, Syrmis, Melanie and Wainwright, Claire (2003). Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics. Journal of Clinical Microbiology, 41 (5), 2266-2267. doi: 10.1128/JCM.41.5.2266-2267.2003
Sherritt, M. A., Bharadwaj, M., Burrows, J. M., Morrison, L. E., Elliott, S. L., Davis, J. E., Kear, L. M., Slaughter, R. E., Bell, S. C., Galbraith, A. J., Khanna, R. and Moss, D. J. (2003). Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from post-transplant lymphoma after adoptive immunotherapy. Transplantation, 75 (9), 1556-1560. doi: 10.1097/01.TP.0000058745.02123.6F
Greer, Ristan M., Buntain, Helen M., Potter, Julia M., Wainwright, Claire E., Wong, Joseph C., O'Rourke, Peter K., Francis, Paul W., Bell, Scott C. and Batch, Jennifer A. (2003). Abnormalities of the PTH-vitamin D axis and bone turnover markers in children, adolescents and adults with cystic fibrosis: comparison with healthy controls. Osteoporosis International, 14 (5), 404-411. doi: 10.1007/s00198-003-1388-1
Antibiotic desensitization in adults with cystic fibrosis
Burrows, J. A., Toon, M. and Bell, S. C. (2003). Antibiotic desensitization in adults with cystic fibrosis. Respirology, 8 (3), 359-364. doi: 10.1046/j.1440-1843.2003.00461.x
Richards, M.L., Bell, S.C., Edmiston, K.A. and Davies, P.S.W. (2003). Assessment of bioelectrical impedance analysis for the prediction of total body water in cystic fibrosis. Asia Pacific Journal of Clinical Nutrition, 12 (2), 161-165.
Kidd, T. J., Bell, S. C. and Coulter, C. (2003). Genomovar diversity amongst Burkholderia cepacia complex isolates from an Australian adult cystic fibrosis unit. European Journal of Clinical Microbiology & Infectious Diseases, 22 (7), 434-437. doi: 10.1007/s10096-003-0949-8
Multi-resistant Pseudomonas aeruginosa (MRPA) in a large adult cystic fibrosis (CF) unit
O'Carroll, M. R., Kidd, T. J., Coulter, C. and Bell, S. C. (2003). Multi-resistant Pseudomonas aeruginosa (MRPA) in a large adult cystic fibrosis (CF) unit. Respirology, 8 (Suppl), A47-A47.
Kidd, T. J., Bell, S. C. and Coulter, C. (2003). The genomovar distribution of Burkholderia cepacia complex isolates collected from Australian cystic fibrosis units. Journal of Cystic Fibrosis, 2 (1 Suppl), S33-S33.
Garske, Luke A., Tam, Robert K.W., Windsor, Morgan F. and Bell, Scott C. (2002). Novel application of biological glue in the management of a complicated pneumothorax in cystic fibrosis. Pediatric Pulmonology, 34 (2), 138-140. doi: 10.1002/ppul.10112
Wolter, J., Seeney, S., Bell, S., Bowler, S., Masel, P. and McCormack, J. (2002). Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: A randomised trial. Thorax, 57 (3), 212-216. doi: 10.1136/thorax.57.3.212
Wolter, J., Seeney, S., Bell, S., Bowler, S., Masel, P. and McCormack, J. (2002). Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial. Thorax, 57 (3), 212-216. doi: 10.1136/thorax.57.3.212
Nebulised dornase alpha: adherence in adults with cystic fibrosis
Burrows, J. A., Bunting, J. P., Masel, P. J. and Bell, S. C. (2002). Nebulised dornase alpha: adherence in adults with cystic fibrosis. Journal of Cystic Fibrosis, 1 (4), 255-259. doi: 10.1016/S1569-1993(02)00095-4
Optimising nutrition in cystic fibrosis
Bell, S. C. and Shepherd, R. W. (2002). Optimising nutrition in cystic fibrosis. Journal of Cystic Fibrosis, 1 (2), 47-50. doi: 10.1016/S1569-1993(02)00031-0
Pamidronate results in symptom control of hypertrophic pulmonary osteoarthropathy in cystic fibrosis
Garske, L. A. and Bell, S. C. (2002). Pamidronate results in symptom control of hypertrophic pulmonary osteoarthropathy in cystic fibrosis. Chest, 121 (4), 1363-1364. doi: 10.1378/chest.121.4.1363
Prevalence of complementary and alternative medicine use by adults with cystic fibrosis
Burrows, J. A., Bajramovic, J. and Bell, S. C. (2002). Prevalence of complementary and alternative medicine use by adults with cystic fibrosis. Journal of Pharmacy Practice and Research, 32 (4), 320-323. doi: 10.1002/jppr2002324320
Azithromycin (azm) in adults with cystic fibrosis (cf)
Welter, J. M., Seeney, S. L., Bowler, S. D., Masel, P. J., Bell, S. C. and McCormack, J. G. (2001). Azithromycin (azm) in adults with cystic fibrosis (cf). Respirology, 6 (SUPPL. 1).
Stallard, K., Seale, H. and Bell, S.C. (2001). Cost of physiotherapy in CF. Thorax, 56 (12), 980-980. doi: 10.1136/thorax.56.12.980
Life-threatening haemoptysis presenting as a late complication of an ovarian tumour
Riha, R. L., Tubby, J., Duhig, E. E., Clarke, B. E., Haug, G. and Bell, S. C. (2001). Life-threatening haemoptysis presenting as a late complication of an ovarian tumour. International Journal of Clinical Practice, 55 (10), 729-730.
Manpower and costings of physiotherapy: an adult cystic fibrosis service
Bell, S. C. and Stallard, K. (2001). Manpower and costings of physiotherapy: an adult cystic fibrosis service. Respirology, 6 (SUPPL. 1).
Pulmozyme adherence in an adult cf unit
Bell, S. C. and Phillips, J. A. (2001). Pulmozyme adherence in an adult cf unit. Respirology, 6 (SUPPL. 1).
Energy cost of physical activity in cystic fibrosis
Richards, M.L., Davies, P.S.W. and Bell, S.C. (2001). Energy cost of physical activity in cystic fibrosis. European Journal of Clinical Nutrition, 55 (8), 690-697. doi: 10.1038/sj.ejcn.1601201
Aminoglycosides in cystic fibrosis: a descriptive study of current practice in Australia
Phillips, J.A. and Bell, S.C. (2001). Aminoglycosides in cystic fibrosis: a descriptive study of current practice in Australia. Internal Medicine Journal, 31 (1), 23-26. doi: 10.1046/j.1445-5994.2001.00010.x
Microvascular complications in cystic fibrosis-related diabetes mellitus: A case report
Scott, Andrew I.R., Clarke, Belinda E., Healy, Helen, D'Emden, Michael and Bell, Scott C. (2000). Microvascular complications in cystic fibrosis-related diabetes mellitus: A case report. Journal of the Pancreas, 1 (4), 208-210.
Metabolic and inflammatory responses to pulmonary exacerbation in adults with cystic fibrosis
Bell, S.C., Bowerman, A.M., Nixon, L.E., Macdonald, I.A., Elborn, J.S. and Shale, D.J. (2000). Metabolic and inflammatory responses to pulmonary exacerbation in adults with cystic fibrosis. European Journal of Clinical Investigation, 30 (6), 553-559. doi: 10.1046/j.1365-2362.2000.00667.x
Bunting, J, Slaughter, RE, Masel, PJ, Kroll, WJ and Bell, SC (2000). Ultrasound placement of peripherally inserted central catheters (PICCs) in adults with cystic fibrosis.. Thorax, 55 (6), 535-535. doi: 10.1136/thorax.55.6.535
Lung volume reduction surgery (LVRS) - The prince charles hospital
Rafter, Lee, Scott, Andrew, Tarn, Robert, Matar, Kevin, Windsor, Morgan, Seale, Helen, Galbraith, Andrew and Bell, Scott (1999). Lung volume reduction surgery (LVRS) - The prince charles hospital. Respirology, 4 (SUPPL. 1).
Khanna, R., Bell, S., Sherritt, M., Galbraith, A., Burrows, S. R., Rafter, L., Clarke, B., Slaughter, R., Falk, M. C., Douglass, J., Williams, T., Elliott, S. L. and Moss, D. J. (1999). Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease. Proceedings of the National Academy of Sciences of the United States of America, 96 (18), 10391-10396. doi: 10.1073/pnas.96.18.10391
Repeatability and methodology of resting energy expenditure in patients with cystic fibrosis
Bell, Scott C., Elborn, J. Stuart, Nixon, Lisette E., Macdonald, Ian A. and Shale, Dennis J. (1999). Repeatability and methodology of resting energy expenditure in patients with cystic fibrosis. Respiration Physiology, 115 (3), 301-307. doi: 10.1016/S0034-5687(99)00008-0
Trepopnoea due to positional narrowing of the left main bronchus
Yang, I.A., Bell, S.C., Fong, K.M. and Aldons, P.M. (1999). Trepopnoea due to positional narrowing of the left main bronchus. Australian and New Zealand Journal of Medicine, 29 (6), 838-839. doi: 10.1111/j.1445-5994.1999.tb00800.x
Nutrition in adults with cystic fibrosis
Bell, S.C., Bowerman, A.R., Davies, C.A., Campbell, I.A., Shale, D.J. and Elborn, J.S. (1998). Nutrition in adults with cystic fibrosis. Clinical Nutrition, 17 (5), 211-215. doi: 10.1016/S0261-5614(98)80061-7
Pulmonary eosinophilia associated with aminoglutethimide
Bell, S.C. and Anderson, E.G. (1998). Pulmonary eosinophilia associated with aminoglutethimide. Australian and New Zealand Journal of Medicine, 28 (5), 670-671. doi: 10.1111/j.1445-5994.1998.tb00672.x
Circulating immunoreactive interleukin-6 in cystic fibrosis
Nixon, Lisette S., Yung, Bernard, Bell, Scott C., Elborn, J.Stuart and Shale, Dennis J. (1998). Circulating immunoreactive interleukin-6 in cystic fibrosis. American Journal of Respiratory and Critical Care Medicine, 157 (6), 1764-1769.
Vitamin A and E and pulmonary function in cystic fibrosis
Watkin, S., Bell, S.C., Wynn, S., Hiller, J., Shale, D.J. and Elborn, J.S. (1998). Vitamin A and E and pulmonary function in cystic fibrosis. Medical Science Research, 26 (2), 97-99.
Blood and sputum sol inflammatory markers
Nixon, L. S., Yung, B., Bell, S. C., Elborn, J. S. and Shale, D. J. (1996). Blood and sputum sol inflammatory markers. Thorax, 51 (SUPPL. 3).
Circulating immunoreactive Interleukin-6 (IL-6) in cystic fibrosis
Nixon, L. S., Yung, B., Bell, S. C., Elborn, J. S. and Shale, D. J. (1996). Circulating immunoreactive Interleukin-6 (IL-6) in cystic fibrosis. Thorax, 51 (SUPPL. 3).
Neutrophil responsiveness in cystic fibrosis patients is affected by clinical state
Nixon, L. S., Yung, B., Bell, S. C., Elborn, J. S. and Shale, D. J. (1996). Neutrophil responsiveness in cystic fibrosis patients is affected by clinical state. Thorax, 51 (SUPPL. 3).
Nutrition and survival in cystic fibrosis
Elborn, J.S. and Bell, S.C. (1996). Nutrition and survival in cystic fibrosis. Thorax, 51 (10), 971-972. doi: 10.1136/thx.51.10.971
Field, Penelope I., Simmul, Rein, Bell, Scott C., Allen, David H. and Berend, Norbert (1996). Evidence for opioid modulation and generation of prostaglandins in sulphur dioxide (SO)(2)-induced bronchoconstriction. Thorax, 51 (2), 159-163. doi: 10.1136/thx.51.2.159
Resting energy expenditure and oxygen cost of breathing in patients with cystic fibrosis
Bell, S.C., Saunders, M.J., Elborn, J.S. and Shale, D.J. (1996). Resting energy expenditure and oxygen cost of breathing in patients with cystic fibrosis. Thorax, 51 (2), 126-131. doi: 10.1136/thx.51.2.126
Can tumor necrosis factor-alpha (TNF-alpha) be reliably measured in blood?
Elborn, J. Stuart, Delamare, Finola, Bell, Scott C. and Shale, Dennis J. (1995). Can tumor necrosis factor-alpha (TNF-alpha) be reliably measured in blood?. Pediatric Pulmonology, 19 (4), 226-230. doi: 10.1002/ppul.1950190407
Candida albicans infection complicating percutaneous gastrostomy in cystic fibrosis
Bell, S.C., Elborn, J.S., Campbell, I.A. and Shale, D.J. (1995). Candida albicans infection complicating percutaneous gastrostomy in cystic fibrosis. British Journal of Clinical Practice, 49 (2), 109-110.
On tumor necrosis factor alpha in CF
Elborn, J. Stuart, Nixon, Lisette, Bell, Scott C. and Shale, Dennis J. (1994). On tumor necrosis factor alpha in CF. Pediatric Pulmonology, 17 (6), 411-411. doi: 10.1002/ppul.1950170615
Inhaled FMLP increases microvascular permeability in the rabbit trachea
Bell, S.C., Rynell, A.-C., Matheson, M.J., Finnimore, A.J. and Berend, N. (1993). Inhaled FMLP increases microvascular permeability in the rabbit trachea. Journal of Applied Physiology, 74 (3), 1337-1341. doi: 10.1152/jappl.1993.74.3.1337
An unusual intrabronchial foreight body in an asthmatic patient
Bell, S.C., Allen, D.H. and Vandenburg, R.A. (1991). An unusual intrabronchial foreight body in an asthmatic patient. Medical Journal of Australia, 154 (4), 291-291.
Burke, A. J., Carter, R., Tolson, C., Congdon, J., Duplancic, C., Bursle, E., Bell, S., Roberts, J. and Thomson, R. (2023). In vitro susceptibility testing of imipenem- relebactam and tedizolid against australian mycobacterium abscessus isolates. ATS 2023 International Conference, Washington, DC USA, 19-24 May 2023. Washington, DC USA: American Thoracic Society. doi: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2968
Duplancic, C., Thomson, R., Wainwright, C. and Bell, S. C. (2019). High incidence of non-tuberculous mycobacteria-positive cultures among children with cystic fibrosis in Australia. Unknown, Unknown, Unknown. Hoboken, NJ USA: John Wiley & Sons.
Stockwell, R. E., Thomson, R., Leong, L. E., Wheeler, N. E., Bryant, J., Wood, M. E., Sherrard, L. J., Carter, R., Tolson, C., Rogers, G., Wainwright, C., Parkhill, J., Floto, R. A. and Bell, S. C. (2019). Mycobacterium abscessus point source outbreak in the local potable water supply affecting people with cystic fibrosis. Annual North American Cystic Fibrosis Conference, Nashville, TN, United States, 31 October - 2 November 2019. Hoboken, NJ, United States: John Wiley & Sons.
Stockwell, R. E., Leong, L., Wheeler, N., Bryant, J., Wood, M. E., Sherrard, L., Thomson, R., Rogers, G., Wainwright, C., Parkhill, J., Floto, R. A. and Bell, S. C. (2018). PREVALENCE OF SHARED MYCOBACTERIUM ABSCESSUS COMPLEX IN THE QUEENSLAND CYSTIC FIBROSIS POPULATION. HOBOKEN: WILEY.
Infection control in Australian and New Zealand cystic fibrosis centres
Stockwell, R., Wood, M., Moore, V and Bell, S. (2018). Infection control in Australian and New Zealand cystic fibrosis centres. ANZSRS/TSANZ Annual Scientific Meeting, Adelaide, Australia, 23-27 March 2018. Richmond, VIC, Australia: Wiley-Blackwell.
Sherrard, L., Tai, A., Wee, B., Ramsay, K., Kidd, T., Ben Zakour, N., Whiley, D., Beatson, S. and Bell, S. C. (2016). Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in cystic fibrosis. Annual North American Cystic Fibrosis Conference, Orlando, FL, United States, 27-29 October 2016. Hoboken, NJ, United States: John Wiley & Sons.
Tai, A., Kidd, T., Ramsay, K., Bell, S. and Whiley, D. (2014). Evidence of Cross-Transmission of a Multidrug Resistant (Mdr) Pseudomonas Aeruginosa Strain in Patient with Cystic Fibrosis (Cf). Annual Scientific Meeting of the Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science 2014, Adelaide, SA Australia, 4-9 April 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12263_10
Wainwright, C., Bell, S., Morton, J., Ryan, G., Serisier, D., Bye, P., Mulrennan, S., Daley, C. and Greville, H. (2014). The Effect of Ivacaftor in Individuals with Cystic Fibrosis and Severe Lung Disease: Analysis of Data From the Australian Named Patient Programme. Annual Scientific Meeting of the Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science 2014, Adelaide, SA Australia, 4-9 April 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12263_10
Kidd, T. J., Magalhaes, R. J. Soares, Paynter, S. and Bell, S. C. (2013). The Social Network in Cystic Fibrosis (Cf) Centre Care and the Risk of Shared Pseudomonas Aeruginosa (Pa) Strain Infection. HOBOKEN: WILEY-BLACKWELL.
Wood, M. E., Ramsay, K. A., Kidd, T. J. and Bell, S. C. (2013). Methicillin-Resistant Staphyloccus Aureus (Mrsa) Infection in Health Care Workers with Cystic Fibrosis (Hcwcf). 2013 Annual Scientific Meetings of The Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science, Darwin, NT Australia, 22 - 27 March 2013. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12045
Tai, A., Kidd, T. J., Whiley, D. M., Sidjabat, H. E. and Bell, S. C. (2013). Molecular Surveillance and Prevalence of Acquired Carbapenem Resistance in Pseudomonas Aeruginosa (Pa) Amongst Australian Cystic Fibrosis (Cf) Patients. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science 2013 Annual Scientific Meetings, Darwin Convention Centre, Darwin, NT, 22-27 March 2013. Richmond Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12046
Wood, M. E., Smith, D. J., Reid, D. W. E. C. and Bell, S. C. (2013). Observational Study of the Clinical Effects of Ivacaftor in Patients with Severe Cystic Fibrosis (Cf) Lung Disease. 2013 Annual Scientific Meetings of The Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science, Darwin, NT Australia, 22 - 27 March 2013. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12046
Perturbation of Sputum Microbiota by Intravenous Antibiotics in Cystic Fibrosis Is Short-Lived
Smith, D. J., Badrick, A. C., Krause, L., Bell, S. C., Anderson, G. J. and Reid, D. W. (2013). Perturbation of Sputum Microbiota by Intravenous Antibiotics in Cystic Fibrosis Is Short-Lived. 2013 Annual Scientific Meetings of The Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science, Darwin, NT Australia, 22 - 27 March 2013. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12046
Viability of pseudomonas aeruginosa (Pa) in cough aerosols from adult cystic fibrosis (CF) patients
Kidd, T. J., Knibbs, L. D., Johnson, G., Kattenbelt, J. A., Ramsay, K. A., Wood, M., Beevers, A., O'Rourke, P. K., Wainwright, C. E., Grimwood, K., Sly, P., Morawska, L. and Bell, S. C. (2013). Viability of pseudomonas aeruginosa (Pa) in cough aerosols from adult cystic fibrosis (CF) patients. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science 2013 Annual Scientific Meetings, Darwin, NT Australia, 22-27 March 2013. Richmond, VIC Australia: Wiley-Blackwell. doi: 10.1111/resp.12045
Acquired aminoglycoside resistance in pseudomonas aeruginosa from a cystic fibrosis patient
Hanks-Thomson, Kirstin R., Kidd, Timothy J., Wainwright, Claire E., Ramsey, Kay A., Steen, Jason A., Bell, Scott C., Zakour, Nouri L. Ben and Beatson, Scott A. (2012). Acquired aminoglycoside resistance in pseudomonas aeruginosa from a cystic fibrosis patient. Australian Society for Microbiology Annual Scientific Meeting (ASM2012), Brisbane, Australia, 1-4 July 2012.
Burkholderia cepacia complex infection (bcc) in cystic fibrosis (cf): 2001-2010
Ramsay, K. A., Butler, C., Kidd, T. J., Wainwright, C. E. and Bell, S. C. (2012). Burkholderia cepacia complex infection (bcc) in cystic fibrosis (cf): 2001-2010. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science 2012 Annual Scientific Meetings, Canberra ACT, Australia, 30 March-4 April 2012. Richmond Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2012.02143.x
Smith, D. J., Badrick, A., Anderson, G. J., Bell, S. C. and Reid, D. W. (2012). Iron supplementation and defective iron homeostasis are associated with worse lung function in cystic fibrosis (CF). Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science 2012 Annual Scientific Meetings, Canberra, ACT, 30 March - 4 April 2012. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2012.02142.x
Pseudomonas aeruginosa resistance: Comparison between Australian cystic fibrosis (cf) centres
Smith, D., Kidd, T. J., Ramsay, K. A., Wainwright, C. E., Grimwood, K. and Bell, S. C. (2012). Pseudomonas aeruginosa resistance: Comparison between Australian cystic fibrosis (cf) centres. unknown, unknown, unknown. Richmond, VIC, Australia: John Wiley and Sons.
Timothy Kidd, Kay Ramsay, Bell, Scott C., Claire Wainwright and Keith Grimwood (2011). Australasian CF bronchoalveolar lavage (ACFBAL) Study: Pseudomonas aeruginosa (Pa) genotypes in pre-school CF children. 9th Australasian Cystic Fibrosis Conference, Melbourme, Australia, 20 - 23rd August 2011.
Clonal complex pseudomonas aeruginosa in horses: A model of CF infection
Kidd, Timothy, Gibson, J. S., Moss, S., Greer, R. M., Cobbold, R. N., Wright, J. D., Ramsay, Kay, Grimwood, Keith and Bell, Scott C. (2011). Clonal complex pseudomonas aeruginosa in horses: A model of CF infection. Thoracic Society of Australia and New Zealand Annual Scientific Meeting, Perth, Australia, 2-6 April 2012.
Comparison of clinical and environmental Pseudomonas aeruginosa: evidence for recombination
Timothy Kidd, Ritchie S, Keith Grimwood, Bell, Scott C. and Rainey PB (2011). Comparison of clinical and environmental Pseudomonas aeruginosa: evidence for recombination. 34th European Cystic Fibrosis Conference, Annual Scientific Meeting, Hamburg, Germany, 8-11 June 2011.
Smith DJ, Timothy Kidd, Kay Ramsay, Keith Grimwood, Claire Wainwright and Bell, Scott C. (2011). Pseudomonas aeruginosa antibiotic resistance: comparison between Australian paediatric and adult cystic fibrosis centres. 9th Australasian Cystic Fibrosis Conference, Melbourme, Australia, 20-23rd August 2011.
Timothy Kidd, Kay Ramsay, He Hu, Bye P, Elkins M, Marks G, Claire Wainwright, robinson P, Rose B, Harbour C, Keith Grimwood, Bell, Scott C. and ACPinCF Investigator Study Group (2011). Widespread prevalence of related Pseudomonas aeruginosa strains within Australian cystic fibrosis centres. 9th Australasian Cystic Fibrosis Conference, Melbourne , Australia, 20-23 August 2011.
Tse, T., Hopkins, P. M. A., France, M. W., Masel, P. J., Bell, S. C., Kermeen, F. D. and Chambers, D. C. (2010). Antibiotic desensitisation in cystic fibrosis patients with a history of hypersensitivity undergoing lung transplantation is not mandatory. 30th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation, Chicago Il, Apr 21-24, 2010. ELSEVIER SCIENCE INC.
Clonal pseudomonas aeruginosa (PA) in Australians with cystic fibrosis (CF)
Kidd, T. J., Ramsay, K. A., Hu, H., Bye, P. T. P., Marks, G. B., Wainwright, C. E., Robinson, P. J., Rose, B. R., Harbour, C., Grimwood, K., Bell, S. C. and ACPinCF Investigator Study Group (2010). Clonal pseudomonas aeruginosa (PA) in Australians with cystic fibrosis (CF). Thoracic Society of Australia and New Zealand Annual Scientific Meeting, Brisbane, QLD Australia, 20-24 March 2010.
Multilocus sequence typing (MLST) of Pseudomonas aeruginosa
Kidd, T. J., Rainey, P. B., Ramsay, K. A., Grimwood, K., Wainwright, C. E. and Bell, S. C. (2010). Multilocus sequence typing (MLST) of Pseudomonas aeruginosa. Thoracic Society of Australia and New Zealand Annual Scientific Meeting, Brisbane, Qld Australia, 20-24 March 2010.
Kidd, T. J., Rainey, P. B., Ramsay, K. A., Grimwood, K., Wainwright, C. E. and Bell, S. C. (2010). Multilocus sequence typing (MLST) of Pseudomonas aeruginosa collected from different ecological niches. Australian Society for Microbiology 51st Scientific Meeting, Sydney, NSW, Australia, 4-8 July 2010.
Kidd, T. J., Rainey, P. B., Ramsay, K. A., Grimwood, K., Wainwright, C. E. and Bell, S. C. (2010). Multilocus sequence typing (MLST) of Pseudomonas aeruginosa collected from different ecological niches. 33rd European Cystic Fibrosis Conference, Valencia, Spain, 16-19 June 2010. Amsterdam: Elsevier Science. doi: 10.1016/S1569-1993(10)60114-2
Antibiotic allergy: Diagnosis and management
Bell, Scott C. (2009). Antibiotic allergy: Diagnosis and management. 23rd Annual North American Cystic Fibrosis Conference, Minneapolis, Minnesota, 15 - 17 October 2009. New York , U. S. A.: Wiley. doi: 10.1002/ppul.21130
Walsh, M. J., Lewindon, P. J., Shepherd, R. W., Greer, R. M., Williamson, R., Pereira, T. N., Frawley, K, Bell, S., Smith, J. L. and Ramm, G. A. (2009). Detection and follow-up of hepatic fibrosis in cystic fibrosis: A role for diagnostic liver biopsy and serum markers in evaluating outcomes of cystic fibrosis liver disease. Australia & New Zealand Medical & Surgical Gastrointestinal Week 2009, Sydney, NSW, Australia, 21 - 24 October 2009. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2009.06050.x
Sawyer, S.M., Farrant, B., Wilson, J., Ryan, G., O'Carroll, M., Bye, P. and Bell, S. (2009). Sexual and reproductive health in men with cystic fibrosis: Consistent preferences, inconsistent practices. North American CF Foundation Conference, Orlando, Florida, USA, 24 October 2008. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.jcf.2009.05.005
Audit of iron infusions in the cystic fibrosis (CF) and bronchiectasis populations
Masel, P. J., Tse, T., Herd, K., Wood, P. and Bell, S. (2007). Audit of iron infusions in the cystic fibrosis (CF) and bronchiectasis populations. 7th Australasian Cystic Fibrosis Conference, Sydney, Australia, 11th - 14th August 2007.
Smith, H., Bell, S. and Nissen, L. (2007). Does antibiotic sensitivity testing for Pseudomonas aeruginosa exacerbations in cystic fibrosis patients influence clinical choice?. SHPA 28th Federal Conference 2007, Convention Centre, Sydney Australia, 8-11 November 2007.
A D-optimal designed population pharmacokinetic study of itraconazole
Hennig, S, Wainwright, C E, Bell, S, Miller, H, Charles, B G and Duffull, S B (2006). A D-optimal designed population pharmacokinetic study of itraconazole. APSA Annual Meeting 2006, Adelaide, Australia, 2-5 December 2006. Adelaide:
Hennig, S., Wainwright, C. E., Bell, S., Miller, H., Charles, B. G. and Duffull, S. B. (2006). A D-optimal designed population pharmacokinetic study of itraconazole capsules and solution in adults with cystic fibrosis. 15th Annual Meeting of the Population Approach Group in Europe, Bruges, Belgium, 14-16 June 2006. PAGE.
Hennig, S, Wainwright, C E, Bell, S, Miller, H, Friberg, L. E. and Charles, B G (2006). Paediatric population pharmacokinetcis (popPK) of itraconazole (ITRA) and its active metabolite hydroxy-itraconazole in cystic fibrosis (CF) and bone marrow transplant patients (BMT). PAGANZ 06 9th Annual Scientific Meeting, Auckland New Zealand / School of Medicine, 7-9 February 2006. Brisbane, Australia: Poppulation Approach Group in Australia and New Zealand.
Hennig, S., Wainwright, C. E., Bell, S. C., Miller, H., Friberg, L. E. and Charles, B. G. (2006). Paediatric population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in cystic fibrosis and bone marrow transplant patients. Population Approach Group Europe: 15th Meeting, Bruges, Belgium, 14-16 June 2006. PAGE.
Hennig, S, Wainwright, C E, Bell, S, Miller, H, Friberg, L. E. and Charles, B G (2006). Pharmacokinetic study of itraconazole leads to new improved dosing regimens for paediatric cystic fibrosis and bone marrow transplant patients. The 6th Annual Health and Medical Research Conference of Queensland, Brisbane, Australia, 23-24 November 2006. Brisbane, Australia: Queensland Health.
Burrows, J., Nissen, L. M., Kirkpatrick, C. M. J. and Bell, S. C. (2005). A study of allergic reactions to beta-lactam antibiotics in adults with cystic fibrosis: What is new?. The Society of Hospital Pharmacists of Australia 27th Federal Conference, Brisbane, 10-13 Nov. 2005. Brisbane: Event Planners Australia.
A study of allergic reactions to beta-lactam antibiotics in an adult cystic fibrosis unit
Burrows, J., Nissen, L. M., Kirkpatrick, C. M. J. and Bell, S. C. (2005). A study of allergic reactions to beta-lactam antibiotics in an adult cystic fibrosis unit. Sixth Australian & New Zealand Cystic Fibrosis Conference, Adelaide, 20-23 Aug. 2005. Australia:
Burrows, J., Nissen, L. M., Kirkpatrick, C. M. J. and Bell, S. C. (2005). A study of desensitisation procedures to beta-lactam antibiotics in adult patients with cystic fibrosis: An update. Sixth Australian & New Zealand Cystic Fibrosis Conference, Adelaide, 20-23 Aug. 2005. Australia:
Antibiotics for acute exacerbations of COPD: A systematic review
Yang, I. A., Kim, S. T. and Bell, S. C. (2005). Antibiotics for acute exacerbations of COPD: A systematic review. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1
Antibiotics in cystic fibrosis (CF): A systematic review
Kim, S. T., Yang, I. A. and Bell, S. C. (2005). Antibiotics in cystic fibrosis (CF): A systematic review. Array, Crete, Greece, 22-25 Jun, 2005. Amsterdam, Netherlands: Elsevier BV.
Antibiotics in cystic fibrosis (CF): A systematic review
Kim, S. T., Yang, I. A. and Bell, S. C. (2005). Antibiotics in cystic fibrosis (CF): A systematic review. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1
Syrmis, M., O'Carroll, M., Iredell, J., Wainwright, C., Coulter, C., Sloots, T., Bell, S. and Nissen, M. (2005). Detection of an integron associated aadB resistance gene in Pseudomonas aeruginosa isolates from patients with CF. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1
Syrmis, M., O'Carroll, M., Iredell, J., Wainwright, C. E., Coulter, C., Sloots, T., Bell, S. C. and Nissen, M. (2005). Detection of an integron associated aadb-resistance gene in Pseudomonas aeruginosa isolates from patients with CF. 28th European Cystic Fibrosis Conference, Crete, Greece, 22-25 Jun, 2005. Amsterdam, Netherlands: Elsevier BV.
Epidemic strain Burkholderia cepacia organisms in Australia
Kidd, T. A., Douglas, J., Bergh, H., Bautista, C., Coulter, C. and Bell, S. C. (2005). Epidemic strain Burkholderia cepacia organisms in Australia. 28th European Cystic Fibrosis Conference, Crete, Greece, 22-25 June 2005. Amsterdam, Netherlands: Elsevier.
Epidemic strain Burkholderia cepacia organisms in Australia
Kidd, T. A., Douglas, J., Bergh, H., Bautista, C., Coulter, C. and Bell, S. C. (2005). Epidemic strain Burkholderia cepacia organisms in Australia. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1
Kim, S. T., Passmore, L., Dent, A. G., Slaughter, R., Yang, I. A., Fong, K. M., Zimmerman, P. V. and Bell, S. C. (2005). Gender difference in prevalence of non-cystic fibrosis bronchiectasis (NCFB) does not influence clinical phenotype. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1
Multi-resistant Pseudomonas aeruginosa in an adult CF unit
Downey, D. G., Masel, P. J. and Bell, S. C. (2005). Multi-resistant Pseudomonas aeruginosa in an adult CF unit. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1
Normal bone mass accrual in children and young people with cystic fibrosis - A longitudinal study
Buntain, H. M., Schluter, P. J., Greer, R. M., Wong, J., Bell, S., Lewindon, P., Batch, J. and Wainwright, C. E. (2005). Normal bone mass accrual in children and young people with cystic fibrosis - A longitudinal study. TSANZ 2005 Annual Scientific Meeting, Perth, Australia, 18-23 March 2005. Carlton South, Vic., Australia: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00644.x
Pregnancy in cystic fibrosis: Review of a large cystic fibrosis clinic population
Masel, P. J., Bunting, J. P., Matson, A. G. and Bell, S. C. (2005). Pregnancy in cystic fibrosis: Review of a large cystic fibrosis clinic population. 5th Australian and New Zealand Cystic Fibrosis Conference 2005, Adelaide, Australia, 21 August, 2005. North Ryde, N.S.W.: Cystic Fibrosis Australia.
The effect of mucoidy on biofilm formation in cystic fibrosis clinical isolates
Semple, K., Senini, S., Serisier, D., Bowler, S., Bell, S. and McCormack, J. (2005). The effect of mucoidy on biofilm formation in cystic fibrosis clinical isolates. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1
Kermeen, F. D., Kim, S. T., Kidd, T. J., Coulter, C., Greer, R. M. and Bell, S. C. (2005). Transient non-genomovar III Burkholderia cepacia infection is not uncommon in adults with cystic fibrosis. 28th European Cystic Fibrosis Conference, Crete, Greece, 22-25 June 2005. Amsterdam, Netherlands: Elsevier BV. doi: 10.1016/S1569-1993(05)80113-4
Kermeen, F. D., Kim, S. T., Kidd, T. J., Coulter, C., Greer, R. M. and Bell, S. C. (2005). Transient non-genomovar III Burkholderia cepacia infection is not uncommon in adults with cystic fibrosis. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, WA, Australia, 18-23 March 2005. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1
Access to medications for cystic fibrosis (CF) across Queensland
Murphy, J., Burrows, J. and Bell, S. C. (2004). Access to medications for cystic fibrosis (CF) across Queensland. SHPA Qld Branch Conference, Toowoomba, 16-18 July 2004. Australia: SHPA.
Greer, R. M., Buntain, H. M., Francis, P. W., Lewindon, P. J., Batch, J. A., O'Rourke, P. K. and Bell, S. C. (2004). Energy and calcium stores are preserved in girls and young women with CF, independent of disease severity: An explanation for the 'gender gap'?. 18th Annual North American Cystic Fibrosis Conference, St. Louis, U.S.A., 14-17 Oct, 2004. Hoboken, U.S.A.: John Wiley & Sons. doi: 10.1002/ppul.20143
Burrows, J. and Bell, S. C. (2004). Is antibiotic allergy a problem? An audit of allergy to beta-lactam antibiotics in adults with cystic fibrosis (CF). SHPA Qld Branch Conference, Toowoomba, 16-18 July 2004. Australia: SHPA.
Burrows, J. A. and Bell, S. C. (2004). Is antibiotic allergy a problem? An audit of allergy to beta-lactam antibiotics in adults with cystic fibrosis (CF). Thoracic Society of Australia & New Zealand ASM, Sydney, Australia, 19-24 Mar, 2004. Carlton South, Australia: Blackwell Publishing Asia.
Multi-resistant Pseudomonas aeruginosa in a large adult cystic fibrosis unit
Downey, D., Masel, P. J. and Bell, S. C. (2004). Multi-resistant Pseudomonas aeruginosa in a large adult cystic fibrosis unit. 18th Annual North American Cystic Fibrosis Conference, St. Louis, U.S.A., 14-17 Oct, 2004. Hoboken, U.S.A.: John Wiley & Sons.
Hill, D., Rose, B., Pajkos, A., Thompson, B., Bye, P., Elkins, M., MacLeod, C., Bell, S., Aaron, S., Ferris, W. and Harbour, C. (2004). Multiple combination bactericidal testing of multidrug resistant Pseudomonas aeruginosa isolates from the sputa of Australian cystic fibrosis patients in aerobic, anaerobic and biofilm modes of growth. 18th Annual North American Cystic Fibrosis Conference, St. Louis, U.S.A., 14-17 Oct, 2004. Hoboken, U.S.A.: John Wiley & Sons.
Normal fat and lean tissue mass in adults with cystic fibrosis compared with height matched controls
Batch, J., Bell, S., Buntain, H., Francis, P., Greer, R., Lewindon, P., Wainwright, C. and Wong, J. (2004). Normal fat and lean tissue mass in adults with cystic fibrosis compared with height matched controls. Thoracic Society of Australia and New Zealand 2004 Annual Scientific Meeting, Sydney, Australia, 4 March, 2004. Blackwell.
Nutritional status is similar in CF males and females with end stage cystic fibrosis
Greer, R., Matson, A., Williamson, S., Franks, C., Masel, P., Hopkins, P., Bunting, J. and Bell, S. (2004). Nutritional status is similar in CF males and females with end stage cystic fibrosis. TSANZ 2004 Annual Scientific Meeting, Sydney, NSW, Australia, 4 March 2004. Blackwell.
Kermeen, F. D., Kim, S. T., Kidd, T. J., Coulter, C., Greer, R. M. and Bell, S. C. (2004). Transient non-genomovar III Burkholderia cepacia infection is not uncommon in adults with cystic fibrosis. 18th Annual North American Cystic Fibrosis Conference, St. Louis, U.S.A., 14-17 Oct, 2004. Hoboken, U.S.A.: John Wiley & Sons.
Vitamin A levels in patients with CF are influenced by the inflammatory response
Batch, J., Bell, S., Buntain, H., Francis, P., Greer, R., Lewindon, P., Potter, J., Wainwright, C. and Wong, J. (2004). Vitamin A levels in patients with CF are influenced by the inflammatory response. Thoracic Society of Australia and New Zealand 2004 Annual Scientific Meeting, Sydney, Australia, 4 March, 2004. Blackwell.
Masel, P. J., Bunting, J. P., Franks, C., Kim, S., Kidd, T. J. and Bell, S. C. (2003). Achromobacter xylosoxidans and stenotrophomonas maltophilia in an adult cystic fibrosis population: prevalence and clinical characteristics. 5th Australian & New Zealand Cystic Fibrosis Conference 2003, Melbourne, 21-23 Aug, 2003.
Burkholderia pseudomallei: Another emerging pathogen in cystic fibrosis
O'Carroll, M. R., Kidd, T. J., Coulter, C., Smith, H., Rose, H., Harbour, C. and Bell, S. C. (2003). Burkholderia pseudomallei: Another emerging pathogen in cystic fibrosis. TSANZ ASM 2003, Adelaide, SA, 4 – 9 April 2003. Carlton South, Australia: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2003.supp_1.x
Matson, A., McMahon, S., Bell, S. C., Batch, J. and Francis, P. (2003). Differences in lung function, growth parameters and frequency of hospital admissions between adolescents with cystic fibrosis-related diabetes and controls. 26th European CF Conference, Belfast, Ireland, 5–7 June 2003. Amsterdam, Netherlands: Elsevier. doi: 10.1016/S1569-1993(03)00027-4
Gender differences in CF phenotype associated with low bone mineral density
Greer, R., Bell, S. C., O'Rourke, P., Buntain, H., Batch, J. and Francis, P. (2003). Gender differences in CF phenotype associated with low bone mineral density. 26th European CF Conference, Belfast, Ireland, June 5–7 2003. The Netherlands: Elsevier. doi: 10.1016/S1569-1993(03)00027-4
Gender differences in CF phenotype associated with low bone mineral density
Greer, R., O'Rourke, P. K., Buntain, H. M., Batch, J. A., Francis, P. W. and Bell, S. C. (2003). Gender differences in CF phenotype associated with low bone mineral density. 26th Congress of the European Cystic Fibrosis Society, Belfast, 5 Jun, 2003. Amsterdam: Elsevier BV.
Presence of epidemic Pseudomonas aeruginosa shared between paediatric and adult cystic fibrosis
O'Carroll, M. R., Bell, S. C., Coulter, C., Wainwright, C. E., Nissen, M., Sloots, T. and Syrmis, M. (2003). Presence of epidemic Pseudomonas aeruginosa shared between paediatric and adult cystic fibrosis. TSANZ 2003 Annual Scientific Meeting, Adelaide, Australia, 4-9 April, 2003. Carlton South, Australia: doi: 10.1111/j.1440-1843.2003.supp_1.x
Presence of epidemic Pseudomonas aeruginosa shared between paediatric and adult cystic fibrosis
O'Carroll, M. R., Coulter, C., Bell, S. C., Syrmis, M., Wainwright, C. E., Nissen, M. and Sloots, T. (2003). Presence of epidemic Pseudomonas aeruginosa shared between paediatric and adult cystic fibrosis. 26th European CF Conference, Belfast, Ireland, 5–7 June , 2003. Netherlands: Elsevier Science. doi: 10.1016/S1569-1993(03)00027-4
Garske, L., Bell, S. C., Beatson, S., Walsh, S., Mattick, J., Leach, A. and Whitchurch, C. (2003). Pseudomonas aeruginosa exposed to sub-inhibitory ceftazidime or tobramycin has reduced homoserine lactones. The Thoracic Society of Australia and New Zealand 2003 Annual Scientific Meeting, Adelaide, Australia, 4 - 9 April 2003. Carlton, VIC: Blackwell Science. doi: 10.1111/j.1440-1843.2003.supp_1.x
Rapid genotyping of Pseudomonas aeruginosa using repetitive element based PCR assays
O'Carroll, M. R., Coulter, C., Bell, S. C., Syrmis, M., Wainwright, C. E., Nissen, M. and Sloots, T. (2003). Rapid genotyping of Pseudomonas aeruginosa using repetitive element based PCR assays. 26th European CF Conference, Belfast, Ireland, 5–7 June , 2003. Netherlands: Elsevier Science. doi: 10.1016/S1569-1993(03)00027-4
Rapid genotyping of Pseudomonas aeruginosa using repetitive element based PCr assays
O'Carroll, M. R., Bell, S. C., Coulter, C., Wainwright, C. E., Nissen, M., Sloots, T. and Syrmis, M. (2003). Rapid genotyping of Pseudomonas aeruginosa using repetitive element based PCr assays. TSANZ 2003 Annual Scientific Meeting, Adelaide, Australia, 4-9 April, 2003. Carlton South, Australia: doi: 10.1111/j.1440-1843.2003.supp_1.x
Kidd, T. J., Bell, S. C., Coulter, C. and Lumb, R. (2003). The use of 16s rDNA restriction fragment length polymorphism analysis for the identification of non-fermenting gram negative bacilli in a cystic fibrosis microbiology referral service. 26th European CF Conference, Belfast, Ireland, 5–7 June 2003. Elsevier B.V.. doi: 10.1016/j.jcf.2004.06.005
Greer, R., Richards, M. L., Davies, P.S.W. and Bell, S. C. (2003). Total energy expenditure in cystic fibrosis: Comparison of meast by doubly labelled water vs. heart rate monitoring. 26th European Cystic Fibrosis Conference, Belfast, 5 June 2003. Amsterdam: Elsevier BV.
Greer, R., Bell, S. C., Richards, M. L. and Davies, P.S.W. (2003). Total energy expenditure in cystic fibrosis: Comparison of measurement by double labelled water vs heart rate technique. 26th European Cystic Fibrosis Conference, Belfast, Ireland, 5–7 June 2003. Amsterdam, Netherlands: Elsevier BV. doi: 10.1016/S1569-1993(03)00027-4
Vitamin A is associated with the inflammatory marker CRP in cystic fibrosis
Greer, R., Buntain, H. M., Wainwright, C. E., Batch, J. A., Francis, P. W. and Bell, S. C. (2003). Vitamin A is associated with the inflammatory marker CRP in cystic fibrosis. 26th Congress of the European Cystic Fibrosis Society, Belfast, Ireland, 5 Jun, 2003. Amsterdam: Elsevier BV. doi: 10.1016/j.jcf.2004.06.005
Phillips, J., Bajramovic, J. and Bell, S. (2002). A study of the use of complementary and alternative medicines (CAM) in adults with cystic fibrosis (CF). TSANZ Annual Scientific Meeting, Cairns, 22-27 Mar, 2002. Carlton: Blackwell Asia.
Age appropriate pubertal development in cystic fibrosis
Buntain, H., Greer, R. M., Schluter, P., Batch, J., Bell, S. C. and Wainwright, C. E. (2002). Age appropriate pubertal development in cystic fibrosis. The 16th Annual North American Cystic Fibrosis Conference, Louisiana, 3-6 October, 2002. New York: Wiley-Liss. doi: 10.1002/ppul.70012
Antibiotic desensitisation in adults with cystic fibrosis
Burrows, J., Toon, M. and Bell, S. C. (2002). Antibiotic desensitisation in adults with cystic fibrosis. SHPA State Conference 2002 - Reducing risk: the cornerstone of hospital pharmacy, Brisbane, 1-3 Nov. 2002. Brisbane: SHPA Qld.
Kidd, T., Coulter, C. and Bell, S. (2002). Burkholderia cepacia (b.cepacia) complex: identification of genomovars in patients with cystic fibrosis (CF). TSANZ Annual Scientific Meeting, Cairns, 22-27 Mar, 2002. Carlton: Blackwell Asia.
Calcium homeostasis in patients with cystic fibrosis
Greer, R., Buntain, H., Wainwright, C., Wong, J., Lewindon, P., Potter, J., Francis, P., O'Rourke, P., Munns, C., Batch, J. and Bell, S. (2002). Calcium homeostasis in patients with cystic fibrosis. TSANZ Annual Scientific Meeting, Cairns, QLD, Australia, 22-27 March 2002. Carlton, VIC, Australia: Blackwell Asia. doi: 10.1111/j.1440-1843.2004.supp_2.x
Changes in nutritional parameters following lung transplantation for end stage cystic fibrosis (CF)
Scott, A., Matson, A., Glanville, A., Morton, J. and Bell, S. (2002). Changes in nutritional parameters following lung transplantation for end stage cystic fibrosis (CF). TSANZ Annual Scientific Meeting, Cairns, 22-27 Mar, 2002. Carlton: Blackwell Asia.
Cost of providing nutritional support for adult patients with cystif fibrosis (CF)
McMillan, J., Matson, A., Matson, K. and Bell, S. (2002). Cost of providing nutritional support for adult patients with cystif fibrosis (CF). TSANZ Annual Scientific Meeting, Cairns, 22-27 Mar, 2002. Carlton: Blackwell Asia.
Bell, S. C., Seeney, S., Walmsley, K., Wolter, J. M., Bowler, S. D. and McCormack, J. G. (2002). Long-term treatment with azithromycin results in reduced ex-vivo inflammatory cytokine production in adults with cystic fibrosis. 16th Annual North American Cystic Fibrosis Conference, Louisiana, USA, 3-6 October, 2002. New York: Wiley-Liss. doi: 10.1002/ppul.70010
Bowler, S. D., Seeney, S., Walmsley, K., Wolter, J.M., Bell, S. C. and McCormack, J. G. (2002). Long-term treatment with azithromycin results in reduced in vitro inflammatory cytokine production in adults with cystic fibrosis. TSANZ Annual Scientific Meeting, Cairns, Queensland, 22-27 March, 2002. Carlton: Blackwell Asia. doi: 10.1111/j.1440-1843.2004.supp_1.x
Portrait of the cystic fibrosis (CF) patient in Australia and New Zealand (NZ) in 1999
Cooper, P., McKay, K., Bobosevich, Z. and Bell, S. (2002). Portrait of the cystic fibrosis (CF) patient in Australia and New Zealand (NZ) in 1999. TSANZ Annual Scientific Meeting, Cairns, 22-27 Mar, 2002. Carlton: Blackwell Asia.
Prevalence of cystic fibrosis-related diabetes (CFRD) in an adult cystic fibrosis (CF) unit
Matson, A., Walker, F., Matson, K. and Bell, S. C. (2002). Prevalence of cystic fibrosis-related diabetes (CFRD) in an adult cystic fibrosis (CF) unit. TSANZ Annual Scientific Meeting, Cairns, 22-27 Mar, 2002. Carlton: Blackwell Asia.
Matson, A. G., Walker, F., Matson, K. M. and Bell, S. (2002). Prevalence of cystic fibrosis-related diabetes (CFRD), in an Australian adult cystic fibrosis (CF) unit. 16th Annual North American Cystic Fibrosis Conference, Louisiana, 3-6 Oct, 2002. New York: Wiley-Liss.
Puberty and bone mineral accrual in cystic fibrosis
Buntain, H. M., Greer, R. M., Batch, J., Wong, J., Lewindon, P., Schluter, P., Bell, S. C., Potter, J. and Wainwright, C. E. (2002). Puberty and bone mineral accrual in cystic fibrosis. TSANZ 2002 Annual Scientific Meeting. Respirology, Cairns, QLD, Australia, 22-27 March 2002. Carlton, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2004.supp_2.x
Garske, L., Bunting, J., Franks, C., Masel, P. and Bell, S. (2002). Rifampicin and fusidic acid reduces the frequency of MRSA isolation and need for intravenous antibiotics in adult patients with cystic fibrosis and chronic MRSA infection. TSANZ Annual Scientific Meeting, Cairns, 22-27 Mar, 2002. Carlton: Blackwell Asia.
Uncoupled bone turnover in cystic fibrosis: bone markers and the PTH-vitamin D axis
Greer, R. M., Buntain, H., Wainwright, C. E., Potter, J. M., Munns, C., O'Rourke, P., Francis, P., Batch, J. and Bell, S. C. (2002). Uncoupled bone turnover in cystic fibrosis: bone markers and the PTH-vitamin D axis. 16th Annual North American Cystic Fibrosis Conference, Louisiana, 3-6 October, 2002. New York: Wiley-Liss. doi: 10.1002/ppul.70012
Seeney, S. L., Bowler, S., Wolter, J.M., Bell, S.C., Masel, P.J. and McCormack, J. G. (2001). A prospective randomized trial of long term azithromycin (AZM) versus placebo in cystic fibrosis (CF): Impact on clinical, laboratory and quality of life (QOL) outcomes. ASID Annual Scientific Meeting, Melbourne, Australia, 7-11 April, 2001. Carlton, Australia: Blackwell Science Asia. doi: 10.1046/j.1445-5994.2001.00318.x
Bowler, S., Wolter, J. M., Seeney, S. L., Bell, S., Masel, P. J. and McCormack, J. G. (2000). A prospective, randomised trial of long term azithromycin (AZM) versus placebo in cystic fibrosis: Impact on clinical, laboratory and quality of life (QOL) outcomes. Fourteenth Annual North American Cystic Fibrosis Confrence, Baltimore Maryland, USA, 9-12 November, 2000. New York, USA: Wiley-Liss, Div John Wiley & Sons.
Aminoglycosides in cystic fibrosis - a descriptive study of current practice in Australia
Phillips, J. and Bell, S. (1999). Aminoglycosides in cystic fibrosis - a descriptive study of current practice in Australia. 3rd Australian Cystic Fibrosis Conference, Sydney, Australia, 26-28 August 1999. Sydney, Australia: Cystic Fibrosis Australia.
Audit of nutritional indicators in adults attending a cystic fibrosis unit in Queensland
Hume, A., Walker, F., Hall, G., Bell, S. and Bunting, J. (1999). Audit of nutritional indicators in adults attending a cystic fibrosis unit in Queensland. 3rd Australian Cystic Fibrosis Conference, Sydney, Australia, 26 - 28 August 1999. Sydney, Australia: Cystic Fibrosis Australia.
Bronchial artery embolisation in patients with cystic fibrosis
Masel, P. J., Slaughter, R. and Bell, S. (1999). Bronchial artery embolisation in patients with cystic fibrosis. 3rd Australian Cystic Fibrosis Conference, Sydney, Austalia, 26-28 August 1999. Sydney, Australia: Cystic Fibrosis Australia.
Lung volume reduction surgery (LVRS) - the Prince Charles Hospital
Rafter, L., Scott, A., Tam, R., Matar, K., Windsor, M., Seale, H., Galbraith, A. and Bell, S. (1999). Lung volume reduction surgery (LVRS) - the Prince Charles Hospital. Heart and Lungs, National Convention Centre, Canberra, 26 Feb - 3 Mar 1999. Carlton, VIc: Blackwell Science.
Bell, S., Schols, A. W., Dentener, M. S., Elborn, J. S., Shale, D. J. and Buurman, W. A. (1999). Soluble adhesion molecules in TNF (Receptors in plasma of patients with cystic fibrosis (CF) during pulmonary exacerbation (PE). 3rd Australian Cystic Fibrosis Conference, Sydney, Australia, 26-28 August 1999. Sydney, Australia: Cystic Fibrosis Australia.
Totally implanted venous access devices in adults with cystic fibrosis
Bunting, J., Bell, S., Masel, P. J., Slaughter, R. and Kroll, W. (1999). Totally implanted venous access devices in adults with cystic fibrosis. 3rd Australian Cystic Fibrosis Conference, Sydney, Australia, 26 - 28 Aug 1999. Sydney, Australia: Cystic Fibrosis Australia.
Bunting, J., Bell, S., Masel, P. J., Slaughter, R., Kroll, W. and Oreo, S. (1999). Use of ultrasound for placement of peripherally inserted central catheters (PICCs) in adults with cystic fibrosis. 3rd Australian Cystic Fibrosis Conference, Sydney, Australia, 26 - 28 Aug 1999. Sydney, Australia: Cystic Fibrosis Australia.
(2021–2023) South Australian Health and Medical Research Institute Limited
(2020–2023) NHMRC Project Grant
(2020) Prince Charles Hospital Foundation
Early life origins of cystic fibrosis lung disease
(2019–2024) Cystic Fibrosis Foundation USA
Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMAT)
(2019–2024) Cystic Fibrosis Foundation USA
Queensland cystic fibrosis research program
(2019–2024) The Children's Hospital Foundation
(2019) UQ Major Equipment and Infrastructure
Multi-drug resistant non-tuberculous mycobacteria infection research
(2018–2025) Research Donation Generic
(2018–2021) The Children's Hospital Foundation
(2016–2020) Queensland Institute of Medical Research
Macrophages: the forgotten cells in CF lung disease
(2016–2019) Cystic Fibrosis Foundation Therapeutics Inc
(2016–2019) Queensland Institute of Medical Research
Abnormal lung iron homeostasis in cystic fibrosis (NHMRC Project Grant administered by QIMR)
(2015–2017) Queensland Institute of Medical Research
(2014–2016) Prince Charles Hospital Foundation
Purchase of -80C Freezer - XYCYST
(2013–2014) Prince Charles Hospital Foundation
Airborne Infection Transport in Hospitals
(2012–2014) Prince Charles Hospital Foundation
Inflammatory airways disease in children with a focus on cystic fibrosis
(2010–2016) Royal Children's Hospital Foundation
Development of a novel assay for the detection of clonal P.aeruginosa in persons with CF
(2010–2011) Australian Cystic Fibrosis Research Trust
Longitudinal study of clonal Pseudomonas aeruginosa in cystic fibrosis
(2010–2011) Queensland Health
Longitudinal study of clonal Pseudomonas aeruginosa in cystic fibrosis
(2010–2011) Royal Children's Hospital Foundation
(2009–2015) Royal Children's Hospital Foundation
Clinical impact of clonal Pseudomonas aeruginosa in cystic fibrosis
(2007–2010) NHMRC Project Grant
How Children and adults with cystic fibrosis get lung infections with Pseudomonas aeruginosa
(2005–2010) Royal Children's Hospital Foundation
Risk and mitigation of cough aerosols for people with cystic fibrosis.
Doctor Philosophy — Principal Advisor
Other advisors:
Pharmacokinetics of anti-mycobacterial drugs in patients with cystic fibrosis
Doctor Philosophy — Associate Advisor
Other advisors:
(2019) Doctor Philosophy — Principal Advisor
(2019) Master Philosophy — Principal Advisor
Diversity of environmental and clinical Pseudomonas aeruginosa isolates
(2018) Doctor Philosophy — Principal Advisor
Other advisors:
(2016) Doctor Philosophy — Principal Advisor
Other advisors:
Diagnosis, epidemiology and population structure of Pseudomonas aeruginosa in cystic fibrosis.
(2012) Doctor Philosophy — Principal Advisor
Deep Sequencing of Microbial Communities in Cystic Fibrosis Airways
(2022) Doctor Philosophy — Associate Advisor
Other advisors:
(2022) Doctor Philosophy — Associate Advisor